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VOLUME 34, NUMBER 2 
NO VEINS, NO PAIN 
Interventional radiologists at Mallinckrodt 
Institute offer an effective procedure to treat 
the unsightly and painful varicose veins that 
affect millions of Americans—endovenous 
laser ablation, a less invasive alternative to 
the traditional surgical treatment. 
A PROMISING NEW TOOL FOR TRACKING 
MULTIPLE SCLEROSIS 
Researchers in the Biomedical Magnetic Resonance 
Laboratory are working to devise a method for 
determining injury to the myelin sheath around 
nerves, which could have a profound impact on 
predicting the future course of multiple sclerosis 
and other neurodegenerative diseases. 
TAKING BREAST CANCER DIAGNOSIS 
AND TREATMENT FORWARD 
Mallinckrodt Institute is part of a nationwide 
National Cancer Institute clinical trial to determine 
whether digital mammography is as effective as or 
better than standard film-based mammography in 
the early detection of breast cancer. 
32 YEARS OF OUTSTANDING CONTRIBUTIONS 
In 1957 Fred Hodges became a part of medical 
history when Mallinckrodt Institute became 
the first facility in the United States to offer 
neuroradiology services, then a promising addition 
to the field of radiology. 
Visit the MIR web site at 
www.mir.wustl.edu 
ON THE COVER Dione Farria, MD, of the Institute's Breast Imaging section, is 
Washington University's principal investigator for an important study to evaluate 




Teacher of the 
Year 
Since 1985 diagnostic 
radiology senior residents 
annually have honored an 
MIR faculty member who 
has made outstanding 
contributions to resident 
education, by teaching not 
only with a traditional 
course study but through 
example as the residents 
observe and participate in 
the interpretation of clinical 
studies. At the annual resi- 
dents' and fellows' farewell 
dinner in June, Sanjeev 
Bhalla, MD, assistant profes- 
sor of radiology, was named 
the MIR Teacher of the Year. 
Bhalla came to 
Mallinckrodt Institute in 
1995 as a first-year diagnos- 
tic radiology resident. He 
completed the residency 
(chief resident, 1998-1999) 
and a fellowship in chest 
radiology. He has been 
actively involved in resi- 
dent education since 
joining the MIR faculty in 
2000 and currently serves 
as assistant director of the 
Diagnostic Radiology 
Residency Program. 
At the dinner, James 
Goddard, MD, clinical 
neuroradiology fellow, was 
presented with the Fellow 
of the Year award. The 
following MIR faculty 
were honored as Distin- 
guished Teachers: 
• Robert McKinstry, MD, 
PhD, assistant professor 
of radiology 
• Christine Menias, MD, 
assistant professor of 
radiology 
• William Middleton, MD, 
professor of radiology 
• Franz Wippold, MD, 
associate professor of 




Once again, Mallinck- 
rodt Institute physicians 
were included in the list of 
"Best Doctors in St. Louis," 
as reported in the August 
2003 issue of St Louis Mag- 
azine. The 433-member list 
was excerpted from The 
Best Doctors in America 
database, which includes 
approximately 30,000 doc- 
tors in more than 40 medical 
specialties. Best Doctors 
asks thousands of physicians 
worldwide for nominations 
to the list, based on patient 
care rather than academic or 
research excellence. 
Nuclear Medicine 
Farrokh Dehdashti, MD 
Keith Fischer, MD 
Robert Gropler, MD 
Tom MiUer, MD, PhD 
Mark Mintun, MD 
Henry Royal, MD 
Barry Siegel, MD 
Radiation Oncology 
Perry Grigsby, MD 
JeffMichalski, MD 
Robert Myerson, MD, PhD 
Joseph Simpson, MD, PhD 
Marie Taylor, MD 
Radiology 
Claire Anderson, MD 
DeWitte Cross, MD 
Michael Darcy, MD 
Jay Heiken, MD 
David Hovsepian, MD 
William McAlister, MD 
William Middleton, MD 
Barbara Monsees, MD 
Christopher Moran, MD 
Daniel Picus, MD 
David Rubin, MD 
Stuart Sagel, MD 
Marilyn Siegel, MD 
William Totty, MD 
Thomas Vesely, MD 






faculty were recognized f( 
their outstanding contribv 
tions to and excellence in 
medical field. 
JeffMichalski, MD, a 
ciate professor of radiatic 
oncology and chief of the \ 
Radiation Oncology Clinica; 
Division, was inducted as a v 
fellow in the American Col- 
lege of Radiology (ACR) at the 
May 2003 Annual Meeting in 
Washington, DC. Fellowship 
is one of the highest honors 
conferred by the ACR, with 
only about 10 percent of the 
32,000 radiologists, radiation 
oncologists, interventional 
radiologists, and medical 
physicists who comprise the 
membership being selected 
for fellowship. 
David Piwnica-Worms, 
MD, PhD, professor of radiol- 
ogy and of molecular biology 
and pharmacology and chief 
of the molecular radiopharrm- 
cology laboratory, is the 2003- 
2004 president of the Society 
for Molecular Imaging (SMI), 
an international scientific 
organization. As president, 
Piwnica-Worms will host the 
SMI third annual meeting to 
be held September 9-12, 2004 
in St. Louis. 
Henry Royal, MD, profec - 
sor of radiology, was elected 
the 2003-2004 president of th i 
Society of Nuclear Medicine 
(SNM). The society, now in i s 
50"' year, promotes the benei 
rial uses of radioisotopes an' 
radiation, disseminates new 
ideas in nuclear medicine, an I 
stresses the interdisciplinary 
nature of nuclear science. As 
SNM president, Royal also 
serves on the society's Boarc 
of Directors. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
Another honor 
for Perez 
In April 2003, Carlos 
Perez, MD, professor of radi- 
ation oncology and chair of 
the Department of Radiation 
Oncology, received the 
American Radium Society's 
(ARS's) Janeway Medal in 
recognition of his outstand- 
ing scientific contributions. 
The award and associated 
lecture was established in 
1933 in memory of Henry 
Janeway, MD, a pioneer in 
the therapeutic use of 
radium. The medal was pre- 
sented to Perez in April 2003 
at the ARS Annual Meeting 
in Houston, Texas. 
Perez, one of the most 
highly regarded radiation 
oncologists in the world, 
advocates the treating of 
patients' emotional and 
psychological needs as well 
as their physical needs. 
He has made important 
contributions to the clinical 
management of patients, 
especially those with gyne- 
cologic tumors and carci- 
noma of the prostate and of 
the breast. 
He has received 
numerous honors, including 
Gold Medal awards from the 






ogy (ACR), the American 
Society for Therapeutic 
Radiology and Oncology, and 
CRILA/Circulo do Radioter- 
apeutas Ibero-Latinoameri- 
canos. Perez is a trustee of 
the American Board of 
Radiology, a member of 
the National Board of the 
American Cancer Society, 
and an ACR fellow. 
Perez joined the MIR 
faculty in 1964 and was 
named director of the Radia- 
tion Oncology Center in 1976. 
During this time, he initiated 
a training program for radia- 
tion therapy technologists 
and established the Cancer 
Information Center (CIC), the 
first resource facility of its 
kind. The CIC became a role 
model for similar centers 
in the United States and 
abroad. In June 2001, he was 
named chairman of Washing- 
ton University's newly 




Barry Siegel, MD, profes- 
sor of radiology and of medi- 
cine, and chief of the Division 
of Nuclear Medicine, received 
the prestigious Georg Charles 
de Hevesy Nuclear Pioneer 
Award at the Society of Nuclear 
Medicine Annual Meeting in 
June 2003. The award is pre- 
sented annually for distin- 
guished contributions to the 
specialty of nuclear medicine. 
Established in 1960, the 
award honors de Hevesy, a 
1943 recipient of the Nobel 
Prize in chemistry. 
Siegel is widely recognized 
for his clinical and scientific 
expertise and is often called 
upon as a consultant to govern- 
mental organizations, industry, 
medical centers, and universi- 
ties. A distinguished clinician 
and scientist, Siegel has investi- 
gated various applications of 
nuclear medicine, from 
diagnosing thrombosis and pul- 
monary embolism to detecting 
myocardial infarction, and is 
now focusing on the use of 
positron emission tomography 
(PET) in cancer detection. 
MIR's Division of Nuclear 
Medicine was one of the first 
facilities to transition PET from 
research to clinical practice. 
He is an internationally 
recognized expert in the clinical 
uses of radiopharmaceuticals 
and serves as chairman of the 
Radiopharmaceuticals Expert 
Michael Welch, PhD, a past 
recipient of the de Hevesy 
Award, presented the 2003 
award to Barry Siegel, MD 
(right). 
Committee of the United 
States Pharmacopeia Council 
of Experts, and on advisory 
committees to the Food 
and Drug Administration 




At Washington Univer- 
sity's May commencement, 
Daniel Hatfield received the 
35th Annual Hugh M. Wilson 
Award for Meritorious Work in 
Radiology. Established in 1968 
as a tribute to Hugh Wilson, 
MD, the second MIR director, 
the award historically is pre- 
sented to a fourth-year medical 
student who has performed 
outstanding work in basic or 
clinical radiological sciences. 
As part of his elective 
research rotation, Hatfield 
worked with Kyongtae Bae, 
MD, PhD, assistant professor 
of radiology, as a member of 
Bae's research team studying 
radiological imaging for poly- 
cystic kidney disease. The 
research is part of a large, mul- 
ticenter National Institutes of 
Health-sponsored trial and was 
Hatfield's first exposure to 
modern methods of image 
segmentation, manipulation, 
and analysis. After becoming 
familiar with the different kid- 
ney measurement algorithms 
used in the study, Hatfield 
developed two new measure- 
ment algorithms employing 
3-D imaging software. 
Bae was impressed with 
Hatfield's intelligence, work 
ethic, productivity, and 
resourcefulness. "It was a great 
pleasure to mentor a medical 
student who is research- 
minded and knowledgeable 
about many subjects, including 
mathematics, medicine, 
physiology, and radiology." 





no Veins, no Pain 
BY ANNE KESSEN LOWELL so 
There is new hope for millions of 
Americans whose severe varicose 
veins discouraged them from don- 
ning a bathing suit this summer— 
or worse, who spent many an 
afternoon inside, elevating their 
gams to gain temporary relief from 
painful symptoms. Endovenous 
laser ablation is an easy, nearly 
painless procedure that treats 
varicose veins. Endovenous laser 
ablation offers several advantages 
over traditional surgical treatment 
of varicose veins: It is a much 
shorter procedure, uses only a local 
anesthetic, and is more effective. 
Patients can resume normal activi- 
ties immediately after the procedure 
and more strenuous exercise, such 
as running or lifting, within one 
week.   The technique received FDA 
What causes varicose veins? 
Symptomatic varicose veins— 
larger and more painful than 
common surface (or spider) 
veins— affect about 26 million 
Americans. The large size and 
ungainly appearance have earned 
this class of varicose veins adjec- 
We are looking forward to helping varicose 
vein sufferers in the St. Louis area address a 
painful and frequently embarrassing condition. 
approval in February of 2002 and is 
becoming widely used in the United 
States. Endovenous laser ablation is 
performed at MaUinckrodt Institute 
of Radiology at Washington Univer- 
sity Medical Center by interven- 
tional radiologists whose particular 
training and expertise in catheter- 
guided procedures and use of ultra- 
sound guidance systems make them 
well suited to meet the demands of 
the new technique. Michael Darcy, 
MD, professor of radiology and chief 
of interventional radiology, and 
Suresh Vedantham, MD, assistant 
professor of radiology, lead 
MaUinckrodt Institute's development 
of this promising minimally inva- 
sive procedure. 
Left: The fiberoptic laser is inserted into the 
thin catheter. 
tives such as "ropy," "wormy," and 
"knotted." Women are afflicted 
with varicose veins in far greater 
numbers than are men. These veins 
are more common with age-half of 
women in the over-50 age bracket 
suffer from symptomatic varicose 
veins. Risk factors include standing 
in place for long periods, family 
medical history, and pregnancy. 
Retail and factory workers, secu- 
rity guards, and others who stand 
for hours without a break are 
especially susceptible to the devel- 
opment of severe varicose veins. 
Unlike smaller surface veins 
that are typically repaired solely for 
cosmetic reasons, true varicose 
veins are not just unsightly. Not all 
people with varicose veins will 
have symptoms; for others, the 
veins can cause discomfort. Aches, 
Suresh Vedantham, MD, explains the procedure to 
Karen Seifert. 
itching, night cramps, fatigue, and 
sensations of heaviness or restless- 
ness in the affected leg are a daily 
fact of life for many with this 
condition. In some cases, varicose 
veins can lead to chronic venous 
insufficiency, which in turn can 
cause leg swelling, eczema, 
changes in skin pigmentation, 
and ulceration. 
The saphenous vein, a large 
blood vessel running from ankle to 
groin, is the usual culprit in severe 
varicose vein disease. The saphe- 
nous vein transports blood from 
the deep veins in the calf and thigh 
back to the heart. In a healthy vein, 
blood flows upward toward the 
heart, assisted by one-way valves 
in the vein that prevent gravity 
from reversing the flow. However, 
if the valves weaken, blood leaks 
down and pools (or refluxes) in the 
veins in the lower leg. Eventually 
these veins bulge with the pressure 
of the excess blood. As the condi- 
tion worsens, the veins become 
varicose. From the Latin varix, 
varicose is aptly defined as "abnor- 
mal dilatation or enlargement of a 
blood vessel, especially accompa- 
nied by tortuous development." 
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Standard treatment 
Treatment of the saphenous vein, 
the underlying cause of varicose 
veins, is the only effective and lasting 
solution to the problem. "Underlying 
pressure in the saphenous vein must 
be addressed to cure symptomatic 
varicose veins," emphasizes Darcy. 
"Until recently, surgery was the only 
option available. Because it is a 
painful procedure with a long 
recovery period, many people opt 
to do nothing and continue to 
suffer painful symptoms." 
disorders, skin infections, or blood 
clotting disease; and pregnant 
women. Add to that a 30 percent rate 
of recurrence and the potential for 
lasting scars, and you have a proce- 
dure begging for improvement. 
A safer, faster alternative 
With endovenous laser abla- 
tion, patients with varicose veins 
who have endured discomfort and 
embarrassment finally have an 
alternative to the long, often 
bumpy surgical road to treatment 
Patients can resume normal activities immediately 
after the procedure and more strenuous exercise, 
such as running or lifting, within one week. 
Home remedies and lifestyle 
changes-such as weight reduction 
and increased exercise—are ineffec- 
tive for many people with severe 
varicose veins. And while tube-shaped 
compression stockings—thick, hot, 
itchy and far from fashionable-are 
helpful in relieving some of the pain 
associated with varicose veins, they 
are not usually sufficient to com- 
pletely eliminate symptoms. 
Surgical nomenclature for the 
treatment of varicose veins may 
be enough to make patients queasy: 
The procedure is dubbed "vein strip- 
ping." Under general anesthesia, the 
surgeon removes the offending vein 
through a series of incisions. Discom- 
fort, bruising, and numbness in the 
leg are common postsurgical adverse 
effects. Time to full recovery can be 
two to three weeks, and patients can- 
not return to normal everyday activity 
for a week following surgery. The 
surgical option is not appropriate for 
a large subset of patients, including 
the elderly; people with circulatory 
and recovery. Ablation means to 
take away, to remove. Endovenous 
indicates that the procedure takes 
place inside the vein, where the laser 
works its magic. "This procedure 
offers several benefits," says Darcy. 
"It is a noninvasive procedure that 
deals with the root cause of varicose 
veins by addressing the saphenous 
vein. Patients we've treated have 
told us it is virtually painless. And 
early reports indicate a dramatic 
improvement in recurrence rates 
over that of surgery." 
In a comfortable outpatient 
setting, a local anesthetic is applied 
to the vein itself. Through a tiny 
dot-sized incision, which the 
patient feels as a pinprick, a thin 
catheter is placed into the saphe- 
nous vein. Using ultrasound 
imaging, the interventional radiolo- 
gist follows the catheter's position. 
A tiny fiberoptic laser is inserted 
through the catheter. At the end of 
the saphenous vein, the radiologist 
releases laser energy and slowly 
pulls the laser back through the 
catheter, applying heat to the walls 
of the diseased vein. The resulting 
thermal effect causes the vein to 
collapse, putting it out of the blood- 
flow business. With the saphenous 
vein closed, healthy veins pick up 
the slack and transport blood flow 
in the leg in a normal fashion. 
Although vascular surgeons, 
dermatologists, and plastic sur- 
geons are also performing this new 
procedure, interventional radiolo- 
gists are ideally suited to carry out 
laser ablation. "Interventional radi- 
ologists pioneered catheter-based 
treatment methods, and we have 
the most experience in ultrasound 
guidance for minimally invasive 
procedures," says Vedantham. 
Forty minutes after entering 
the procedure room, the patient is 
ready to go home, with nothing 
more than a Band-Aid® to show for 
the experience. Over-the-counter 
pain relievers may be used to 
address minor leg soreness. Most 
patients resume normal routine 
immediately and more strenuous 
activity within a week. Many 
patients will opt to return to the 
office for cosmetic treatment of 
any smaller, accessory veins that 
may linger after treatment of the 
saphenous vein. This follow-up 
requires only surface laser treat- 
ment or sclerotherapy (a simple 
injection that causes the offending 
veins to shrivel and disappear). 
Study documents success 
In the summer of 2003 the first 
long-term study of laser treatment 
for varicose veins validated its 
advantages over surgery. In a study 
of nearly 500 patients treated with 
laser ablation, radiologists at Weill 
Cornell Vascular in New York City 
(where the procedure was devel- 
oped) documented a 98 percent 
success rate and recurrence of less 
than seven percent over two years 
following treatment. Vein stripping, 
| 
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in contrast, results in recurrence 
in about 25 percent of patients. 
Although skin burns and nerve 
damage are theoretical risks of 
laser treatment, none of the 
patients in the Cornell study— 
and no Mallinckrodt Institute 
patients—encountered either com- 
plication. The procedure has not 
yet been approved to treat varicose 
veins in the posterior area of the 
calf, because of the proximity to 
small nerves located in that area. 
But Darcy is optimistic that 
eventually it will be perfected to 
treat varicose veins located any- 
where in the leg. 
Endovenous laser ablation is a 
cost-effective procedure, at less 
than half the cost of vein stripping, 
and patients do not have to take 
time off from work to recover. With 
the release of positive clinical data, 
the procedure may soon be widely 
covered by insurance. 
"We are looking forward to 
helping varicose vein sufferers in 
the St. Louis area address a painful 
and frequently embarrassing condi- 
tion. This is what we do—catheter 
guided procedures and ultra- 
sound," says Darcy. "It's exciting to 
combine our skills with break- 
through medical technology to 
serve so many patients." Dm 
Editor's Note: Doctors Darcy and 
Vedantham are performing this 
laser procedure in the Center for 
Advanced Medicine, a new 
outpatient facility at the corner of 
Forest Park Boulevard and Euclid 
Avenue. Convenient parking 
garages are just across the street. 
If you have varicose veins, call 
314-362-2900 to schedule a free 
consultation with a physician. 
Varicose veins occur in varying degrees in their appearance 
and severity of symptoms, largely dependent on the size of the 
vein affected. Different levels of treatment are available to 
meet the individual needs of each patient. The first line of attack 
against any type of varicose vein disease is to make lifestyle changes: 
maintain a healthy weight, exercise (especially walking or running), 
elevate legs while resting, and wear elastic support stockings. 
Spider veins are the smallest and least symptomatic type of vari- 
cose vein, so called because of the thin, web-like appearance of the veins. 
Spider veins may occur on the face as well as on the legs but are not 
raised or bumpy as are larger varicose veins. Spider veins can be treated 
with sclerotherapy or laser treatment. Sclerotherapy is a simple proce- 
dure—a solution is injected into the vein and causes the vein walls to 
swell and stick together, eventually closing shut. In a short time, the vein 
turns to scar tissue and is no longer visible. Sclerotherapy requires no 
anesthesia, is performed in a doctor's office, and has few adverse effects. 
However, recurrence is common—some veins may require several treat- 
ments to eliminate them, and the procedure cannot prevent spider veins 
from cropping up in new places. Laser treatment for spider veins is also 
relatively painless and easy, performed in the office without anesthesia. 
Laser light is directed at the surface of the skin, along the course of the 
vein. However, like sclerotherapy, laser treatments may need to be 
repeated to be 100 percent effective, and laser treatment does not 
prevent new spider veins from forming. 
For medium-sized varicose veins, a procedure called ambulatory 
phlebectomy may be effective. These veins are frequently very unsightly 
and may cause painful symptoms. Ambulatory phlebectomy can be done 
under local or general anesthetia, and most patients can return to normal 
activity the next day. To remove the vein, the physician makes several 
incisions in the skin, pulls the vein until it breaks, 
and removes it in pieces. Like vein stripping, this 
procedure may cause pain, bruising, and scarring 
(although to a lesser degree than the stripping 
procedure). 
Large, deep varicose veins can be addressed 
with surgical vein stripping or the less invasive 
laser surgery. Large varicose veins are most likely 
to cause painful and irritating symptoms, in addi- 
tion to being unsighuy. Surgical treatment must be 
done under general anesthesia and may keep 
patients from their normal routine for up to three 
weeks; laser treatment requires only a local anes- 
thetic, has few adverse effects and lower recur- 
rence, and has a recovery period of about 24 hours. 
Michael Darcy, MD 
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J 
by Candace O'Connor 
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Above: MR images of human spinal cord, 
obtained by using DTI. Left, top and 
bottom: patients with MS; right (top and 
bottom): patients without the disease. Top 
row: relative anistropy (variation) maps; 
bottom: thoracic vertebra (T2W) images. 
Left: Victor Song, PhD, (left) and 
Joseph Ackerman, PhD, are in the 
positron emission tomography (PET) 
facility used to image small animals. 
Multiple sclerosis 
(MS) is an all- 
too-common neurological 
disorder, affecting some 
400,000 Americans. Its 
basic mechanism is clear: 
A person's immune system 
mistakenly identifies the 
body's own nerve tissue as 
foreign and attacks it, 
causing inflammation. 
Eventually, the fatty myelin 
sheath that acts as a kind 
of insulator around those 
nerves is injured, along 
with the nerve fibers or 
axons themselves. 
Most patients develop a relapsing- 
remitting form of the disease, in which 
flare-ups alternate with long periods of 
remission. Others have primary-pro- 
gressive or progressive-relapsing MS, 
marked by steadily increasing disabil- 
ity from the outset. 
To predict the future course of the 
disease, it is crucial to know whether 
the myelin or the axon has been dam- 
aged, and how much damage has taken 
place. A myelin injury is also more 
treatable than axonal injury, which is 
not currently reversible. And these 
same questions pertain to spinal cord 
injuries, Alzheimer's disease, and a 
host of neurodegenerative diseases. 
"While MS is considered a 
demyelinating disease, some people 
now think that axonal injury may 
occur early in the disease process. But 
nobody knows for sure, because you 
need a noninvasive method to study 
the brain in a patient with MS," says 
Sheng-Kwei ("Victor") Song, PhD, 
assistant professor of radiology. 
In 1999, Song first became inter- 
ested in solving this problem through 
the use of an exciting new method 
called diffusion tensor magnetic reso- 
nance imaging (DTI). Since then, his 
research has had promising results: 
five articles (two articles published in 
the scientific journal Neuroimage 
addressed white matter injury with 
MS-related mouse models), several 
grants, and encouraging preliminary 
findings (culminating this year in a 
major collaborative grant with col- 
leagues in radiology, neurology, bio- 
medical engineering, pharmacology, 
and biophysics). 
"If this method succeeds, the 
biggest impact will be actually seeing 
what type of injury has taken place, so 
the physician can decide what to treat 
and how to treat it," says Song. "This 
method can also be used to see how 
effective that treatment is." 
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Imaging of MS began in the early 
1980s with the advent of magnetic 
resonance imaging (MRI), which is 
routinely used to pinpoint lesions in 
the brains of patients with MS. But 
MRI cannot define whether the dam- 
age affects the myelin or the axons. 
Song, who received his doctoral 
degree and also did his postdoctoral 
training at Washington University, 
wondered whether DTI might help 
clarify this picture. 
After conferring with Anne 
Cross, MD, Department of Neurol- 
ogy, Song decided to use DTI on a 
biologically unusual form of a mouse 
(known as "shiverer" mice, which 
MR image (using DTI): optic nerves of patient 
without MS. 
Doctors John Russell, Anne Cross, and Victor Song 
are born without the myelin sheath 
around their axons) to address the 
question about using DTI to define 
white matter pathology in the brain 
of a patient with MS. A pilot grant 
from the National Multiple Sclerosis 
Society, as well as grants from Wash- 
ington University and the National 
Science Council of Taiwan, sup- 
ported his work. 
Song's findings were encourag- 
ing. In the shiverer mice, water diffu- 
sion perpendicular to the axonal 
fibers (radial diffusion) was signifi- 
cantly higher than diffusion in a 
group of age-matched controls. 
However, the water diffusion parallel 
to the axonal fibers (axial diffusion) 
was unchanged in the shiverer mice, 
whose axons were intact. Song 
concluded, as he said in an article 
based on this research, that these 
findings "may potentially be used to 
differentiate myelin loss versus 
axonal injury." 
At first, scientific journals were 
reluctant to accredit his 
research. One after another turned 
down his work because some review- 
ers were skeptical about such find- 
ings. Finally, in 2002, after a year 
of trying, Neuroimage published 
Song's study. 
Next, he proceeded to further 
validate the method, using a mouse 
model with retinal ischemia, which 
causes damage to the optic nerve. In 
this model, the axonal degeneration 
precedes demyelination in the optic 
nerve of the injured eye. Song and a 
research team noninvasively exam- 
ined the mice after the injury to estab- 
lish the time course of white matter 
degeneration after injury to the eye. 
Their findings supported those of 
Song's hypothesis: Axonal and 
myelin degeneration can be detected 
and differentiated noninvasively using 
in vivo DTI. This time, the reception 
of his work was quite different. 
Neuroimage accepted his paper 
immediately, with publication 
scheduled for November 2003. 
"We showed that by using DTI 
we could predict how early the 
axonal degeneration started and 
when the demyelination took place. 
Further, we could see all this in vivo 
without removing the eye or nerve, 
which was very exciting," says Song. 
The next step, he says, is to test 
this concept on human volunteers. 
Success in mice is a hopeful sign but 
not conclusive, since a mouse system 
is much simpler than the complex 
human anatomy. To begin work on 
this new study, he has again collabo- 
rated with neurologist Anne Cross, 
molecular biologist John Russell, and 
chemist Joseph Ackerman, Song's 
former mentor in Washington 
University's doctoral program. 
f 
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Together, the investigators 
applied for one of three Collaborative 
MS Research Center Awards, granted 
in 2003 by the National Multiple 
Sclerosis Society, to continue this 
research. The five-year award of 
$825,000 supports scientists and 
clinicians from various fields working 
together on MS-related problems. 
Song also received another National 
MS Society Research Grant of 
$497,000 to further support his 
work in this area 
Using animal models at first, and 
then human volunteers, they 
will focus on the problem of optic 
neuritis, an early symptom of MS in 
which patients temporarily—and 
sometimes permanently—lose their 
sight. Through a friend who has MS 
and has developed optic neuritis, Song 
has heard firsthand how difficult and 
frightening it can be. 
"If we can determine whether 
injury involves axons or myelin, then 
perhaps we can look at the optic 
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nerve when patients experience their 
first onset of optic neuritis to see 
how severely the nerve is injured. 
We may be able to tell whether the 
cause is demyelination or some other 
reversible process, or we may be able 
to say whether the problem will get 
better or worse," says Song. 
While this work continues, Song 
is also advancing along parallel lines 
in other diseases. With a pilot grant 
from the Alzheimer's Disease 
Research Center and a two-year 
research contract from Pfizer Inc., 
he is looking at the process of neu- 
rodegeneration in Alzheimer's 
disease. Currently he is using a 
mouse model to develop technolo- 
gies for studying white matter 
degeneration to the spinal cord. 
In the Collaborative MS Research 
Center grant, the investigators will 
work toward creating DTI profiles of 
injury to tissue, differentiating under- 
lying tissue damages and repair in 
MS brain lesions. "I believe that in 
two to three years, we will either 
prove or disprove the feasi- 
bility of using this method 
in humans," says Song. "I 
want to be optimistic and 
say that we will be able to 
prove it works or at least 
will work on some system 
of the body, such as the 
optic nerve. If we can do 
that, it would be a great 
accomplishment." EU 
Editor's Note: For more informa- 
tion about MS, visit the National 
Multiple Sclerosis Society at 
wurw.nmss.org or the Multiple 
Sclerosis Foundation at 
www.msfacts. org. 
COMMON 
SYMPTOMS OF MS 
Each person is affected differently by MS. 
Some of the more common symptoms of this 
disease are listed below. 
Mobility impairment, including loss of balance, 
muscle coordination, partial or complete paralysis 
Impaired vision 
Bladder and bowel problems 
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Clinical trials taking 
breast Cancer diagnosis 
and treatment fowa^ »»> 
Women facing the staggering diagnosis of brea< 
cancer have a rosier outlook, thanks to advances 
in breast imaging and clinical trials. 
Jill Bokern, RN, is the nurse 
coordinator in the Breast Health 
Center at Washington University 
Medical Center. Because she 
worked there and was due for her 
annual screening mammogram, she 
thought she would participate in a 
clinical trial comparing traditional 
film-screen mammography with 
digital mammography. "Why not 
participate in a study if you qualify? 
This one is not painful or inconve- 
nient. We all know that no imaging, 
including mammography, is one 
hundred percent, so if we can fine- 
tune our diagnostic techniques, 
why not?" 
Early Detection Still the Best 
According to the American 
Cancer Society (ACS), there is no 
question that finding a breast can- 
cer early while asymptomatic 
increases the likelihood it will be 
relatively small and will not have 
spread beyond the breast. The best 
way to do that, says the ACS, is by 
a combination of the use of mam- 
mography, clinical breast exam by 
a health professional, and regular 
breast self-exam. The ACS guide- 
lines, updated this year, recom- 
mend that women in their 20s and 
30s have a clinical breast exam by a 
health professional as part of their 
regular check-ups every three 
years, and that breast self-exam 
(BSE) should be an option for 
women starting in their 20s. After 
age 40, women should have a 
breast exam by a health profes- 
sional every year, and should begin 
yearly screening mammograms. 
Jill Bokern, RN, a breast cancer 
survivor and an advocate of 
screening mammography. 
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Advanced age is no reason to stop 
regular mammograms, as long as 
the woman is in good health and a 
candidate for treatment. The ACS 
states that mammograms can miss 
some cancers, but they remain an 
effective and valuable tool for early 
treatment and survival. 
As a nurse/health educator, I 
both preached and followed that 
advice. Thirteen years ago, I sought 
out my doctor when I discovered a 
lump during a regular breast self- 
exam. The resulting clinical mam- 
mogram came back negative. 
Because of that, I delayed follow- 
up until the lump became too large 
to be treated by lumpectomy. 
Had some of the newer tech- 
nology, such as digital mammogra- 
phy been around then, would my 
initial diagnosis and treatment have 
been different? That, in essence, is 
what the DMIST study is trying to 
determine. DMIST stands for the 
Digital Mammographic Imaging 
Screening Trial. Funded by the 
National Cancer Institute and con- 
ducted by the American College of 
Radiology Imaging Network 
(ACRIN), the purpose of this clini- 
cal trial is to determine whether 
digital mammography is as good as 
or better than the standard film- 
based mammography. 
Dione Farria, MD, MPH, assis- 
tant professor of radiology, is the 
principal investigator for the Wash- 
ington University study site. "We 
must find out if the technology is 
new or if it's new and better, espe- 
cially when it costs four to five 
times more than the standard 
screen-film mammography. The 
industry has done well explaining 
"Improving health starts with prevention 
and how physicians communicate with 
patients every step of the process." 
and marketing the digital equip- 
ment even before clinical trials. 
Radiology and health care facilities 
are already replacing old screen 
film equipment with the digital, so 
it's important to know if it is indeed 
better technology." 
Digital Mammography 
From the woman's perspective, 
digital mammography is done 
much in the same way as the tradi- 
tional screen film mammogram, 
including the same breast position- 
ing and compression. The main dif- 
ference is that the mammogram 
can be interpreted on a computer 
instead of on film, allowing for 
image enhancement, magnification 
and manipulation. 
Earlier studies on the use of 
digital versus screen-film mammog- 
raphy had some problems, accord- 
ing to several critics, such as size, 
enrollment bias and the use of only 
one type of digital equipment. Size 
of the study is important to obtain 
enough suspicious mammograms 
to truly evaluate the differences. 
Enrollment bias in the earlier 
smaller studies came about 
because those women in the study 
already had an abnormal or suspi- 
cious screen-film mammogram. 
Because of that, the studies could 
not be used to prove that digital 
For a complete screening mammogram, it is important 
to have both mediolateral oblique and craniocaudal 
views. The white spots on this 45-year-old woman's 
mammograms indicate benign calcifications. 
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mammography could find cancers 
undetectable on screen film mam- 
mography. There were also con- 
cerns that radiologists were biased, 
knowing the enrollment require- 
ment of an abnormal film-screen 
mammogram. Using participants 
with no anticipation of cancer and 
enrolled for routine screening is 
thought to be the only way to 
objectively compare the two forms 
of mammography. 
The DMIST study has a goal of 
49,500 participants in the United 
States and Canada. Says Farria, 
"We now have about forty-one 
thousand women enrolled across 
the thirty-five sites. Washington 
University has twenty-seven hun- 
dred patients in the study, and we 
are stiU recruiting." The DMIST 
study is the largest, most compre- 
hensive one to date, evaluating 
digital technology across four dif- 
ferent manufacturers of digital 
equipment. 
Farria says that even with the 
in-depth look at digital mammogra- 
phy, no one technology solves all 
diagnostic problems. Screen-film 
mammography, digital mammogra- 
phy, ultrasound, and even magnetic 
resonance imaging are used, some- 
times together, for definitive diag- 
noses. Washington University 
supports clinical trials and critical 
review of published data before 
>» 
Additional studies available to high-risk women 
The STAR Trial: One of the largest breast cancer prevention studies ever, the Study of 
Tamoxifen and Raloxifene, or STAR trial, is recruiting volunteers at more than 500 
centers across the United States, Puerto Rico and Canada. The trial will include 
22,000 postmenopausal women at increased risk of breast cancer to determine 
whether the osteoporosis prevention drug raloxifene (Evista®) is as effective in reducing 
the chance of developing breast cancer as is tamoxifen (Nolvadex®). The Siteman 
Cancer Center at Washington University and Barnes-Jewish Hospital is one of the 
trial centers in St. Louis. For more information about STAR and a list of partici- 
pating centers, call the National Cancer Institute's Cancer Information Service at 
1 -800-422-6237 or go to http://www.nci.nih.gov/clinicaltrials/digestpage/STAR. 
The Sisters Study: For sisters of women who have had breast cancer. Few breast can- 
cer studies have focused on the potential role of the environment or on the interaction 
between the environment and genes. Sisters of women with breast cancer are at 
higher risk for developing breast cancer themselves. Sisters share some of the same 
genes and early life exposures, which may explain their higher risk. By studying the 
sisters of women with breast cancer and following them over time, researchers hope to 
learn a great deal about the risk factors for breast cancer. 
The 50,000 women who join in this effort will provide information about their health, 
lifestyle, and environment. They will be asked to update some of that information 
annually for 10 or more years. As part of the study, researchers will compare the 
information (provided by sisters who develop breast cancer and by those who do not) 
to identify clues to the causes of breast cancer and ways to prevent it. Women are 
eligible for the Sister Study if they live in the United States, have never had breast 
cancer, are 35 to 74 years old, and have a full or half sister with breast cancer, living 
or deceased. For more information, go to http://www.sisterstudy.org. 
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Breast Ultrasound 
Part of the problem with my negative mammogram may have been my very 
dense breast tissue. This type of tissue can obscure lesions on mammograms. Ultra- 
sound breast imaging is not limited by breast tissue density. Another multicenter 
ACRIN trial that will get underway in early 2004 will evaluate screening breast ultra- 
sound in high-risk women. "We are in the final stages of getting ready to accept 
patients," says Farria. She and Maria Schmidt, MD, assistant professor of radiology, 
who directed the breast cancer education team, will be co-principal investigators for 
that study. Physicians who wish to refer patients will be given contact information 
when enrollment is open. Candidates for this study are women with dense breast 
tissue who might be at high risk for the following reasons: having the BRCA 1 or 2 
breast cancer gene, a strong family history of breast cancer, past diagnosis of breast 
cancer, or a high risk lesion from a prior breast biopsy. Participants will receive 
annual screening mammograms and screening ultrasound tests for three years. This 
study will be limited to about 200 participants. 
Dione Farria, MD, in the reading roam in the Breast 
Health Center on the fifth floor of the Center for 
Advanced Medicine. 
investing in technology that might 
not improve quality of care. 
Beyond that, University 
researchers want to determine the 
most appropriate applications for 
each modality. Farria encourages 
physicians to keep abreast of new 
and existing clinical trials and to 
refer their patients as appropriate. 
"Clinical trials not only help to 
ensure technology is used appro- 
priately and cost-effectively, but 
can improve quality of care and 
treatment outcomes for current 
patients and for other patients yet 
to come." 
Candidates for the DMIST trial 
at the Washington University site 
must meet the following criteria: 
> Be present for their normal 
screening mammogram at their 
normal screening interval 
> No symptoms of breast 
pathology 
> No personal history of breast 
cancer 
> No breast implants 
> Cannot be pregnant. 
Study participants will come to 
Washington University Medical 
Center for a regular screening 
mammogram with the standard 
screen-film method. They will also 
have a digital mammogram. The 
following year, participants will 
return to the medical center for a 
16 
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"Clinical trials...can improve quality of care 
and treatment outcomes for current patients 
and for other patients yet to come." 
regular screen-film mammogram or 
provide one from another facility if 
they are not able to return. Most 
women will be finished at that 
point. A small subgroup of women 
will receive follow-up phone calls 
for two to three years about subse- 
quent mammograms and breast 
health. Farria expects official 
results of the study to be published 
in 2005-2006. 
She adds that she is pleased to 
lead this study site because of her 
long-time interest in women's 
health and prevention. "This is a 
wonderful place to be based 
because our Breast Health Center 
has some exceptional specialists 
involved in women's care. In many 
community hospitals, the radiolo- 
gists are generalists. At Washington 
University, we have mammography 
radiology specialists. The same 
applies in treatment. We have sur- 
geons who specialize in breast 
surgery. The more time a doctor 
devotes to an area, the more 
skills are gained and expertise 
is developed." 
Farria's background includes a 
Masters in Public Health, postgrad- 
uate work in preventive medicine, 
and a fellowship in health services 
research, in addition to her work in 
radiology. Her interest does not 
start and stop with diagnosis and 
treatment. She is an advocate for 
women's physical and fiscal health. 
She was also a member of a multi- 
disciplinary team developing com- 
munication materials on breast 
cancer diagnosis and treatment for 
women, including minority women 
and those with little formal educa- 
tion. "I have a strong interest in 
quality of care and making cost- 
effective choices. Improving health 
starts with prevention and how the 
health care team communicates 
with patients every step of the 
process." 
Bokern echoes her enthusiasm: 
"I'm so thankful I work in such a 
wonderful place, and I bless people 
who do clinical trials. It makes our 
lives healthier, happier and longer." 
Her comments have a personal 
context. As a DMIST study partici- 
pant, Bokern was diagnosed with 
breast cancer. 
Breast cancer will become less 
of a threat as women take advan- 
tage of all the resources available 
to them: researching and using edu- 
cational materials, becoming 
The American College of Radiology Imaging Network 
(ACRIN) is a National Cancer Institute-funded 
cooperative group that manages clinical trials. At 
the 2003 ACRIN Annual Meeting in September, 
Darlene Bird, RT(M), research coordinator, received 
a Certificate of Achievement Award for her role in 
recruiting participants for the DMIST study. The 
Washington University site now has the largest 
number of participants than any of the other 34 sites. 
At left is Bruce Hillman, MD, ACRIN chairman, and 
Daniel Sullivan, MD, NCI associate director. 
trained in breast self-examination, 
having recommended exams and 
screening tests on schedule, partic- 
ipating in clinical trials where 
appropriate, and using physicians 
who have strong backgrounds in 
detection and treatment. Bokern 
has been treated for her breast can- 
cer and is back at work, educating 
women and encouraging them to 
take advantage of clinical trials. EU 
Editor's Note: Patients will be enrolled in 
the Digital Mammographic Imaging 
Screening Trial through October 27, 2003. 
If you are interested in participating, 
call the Washington University Medical 
Center Volunteer for Health office at 
(314) 362-1000, line 6. 
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g Contributions. 
Fred Jenner Hodges III, MD, professor of 
radiology, came to medicine quite naturally, 
having come from a family of physicians. 
His father, Fred Jenner Hodges II, was 
professor and chair of the Department of 
Radiology at the University of Michigan. And 
the family's ancestors include Edward Jenner, 
MD, who discovered the smallpox vaccine. 
I   w_ 
Above: MIR neuroradiology section: (left to right) doctors Mokhtar Gado, Hodges, 
Wippold, Robert McKinstry, Katie Vo, Joshua Shimony, and DeWitte Cross. Not 
shown are doctors Colin Derdeyn, Christopher Moran, and Alan Williams. 
Left: Gilbert Jost, MD, director of Mallinckrodt Institute, presents a commemorative 
plaque to Fred Hodges, MD, in recognition of his 32 years at the Institute. Franz Wippold, MD, chief of 
neuroradiology, presents 
Hodges with a proclamation 
from St. Louis Mayor Francis 
Slay, marking April 23 as 
Fred Jenner Hodges Day. 
Hodges first came to Mallinck- 
rodt Institute in 1957 as an 
assistant professor of radiol- 
ogy. That same year MIR Director 
Hugh Wilson, with the assistance of 
Torgny Greitz, MD, from Sweden 
(where neuoradiology was devel- 
oped), established the neuroradiol- 
ogy section. This recent and 
promising addition to the field of 
radiology was not available in other 
United States medical centers, so 
Mallinckrodt Institute quickly 
became a leader in the subspecialty. 
Hodges was named head of MIR's 
neuroradiology program in 1958. 
During his time at MIR, Hodges 
received a National Institutes of 
Health Fellowship in Neuroradiology 
and spent one year in Gothenburg, 
Sweden. He left MIR in 1966 to 
become chief of neuroradiology at 
Johns Hopkins Hospital in Balti- 
more, Maryland. He returned to 
Mallinckrodt Institute in 1980 as pro- 
fessor of radiology and codirected 
the neuroradiology section with 
Mokhtar Gado, MD. 
Hodges is a past president of 
the American Society of Neuroradi- 
ology and a reviewer for the Ameri- 
can Journal of Neuroradiology. In 
1975, he served on the Panel of Con- 
sultants to the Commis- 
• sion on CIA Activities 
within the United States, 
reviewing the circum- 
stances of the assassina- 
tion of President John F. 
Kennedy. He served for 21 
years as a guest examiner 
for the American Board of 
Radiology. 
In April 2003 Hodges retired 
from Mallinckrodt Institute. After a 
career that spans nearly six decades, 
including 32 years of practicing diag- 
nostic radiology at the Institute, he 
plans a quiet retirement—maybe put- 
tering around his Webster Groves 
garden and some travelling. EH3 
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In this section, the names of employees who are full-time 
faculty or staff or who have an appointment in the 
Department of Radiology or Department of Radiation 
Oncology are highlighted in boldface type. 
JOINT 
APPOINTMENT 
Joel Perlmutter, MD, 
professor of neurology, of 
neurological surgery, and of 
radiology, was appointed 
professor of physical therapy 
at Washington University in 
St. Louis. 
NEW FACULTY 
Jennifer Gould, MD, 
instructor in radiology, Divi- 
sion of Diagnostic Radiology, 
Department of Radiology. 
Wen Li, PhD, research 
instructor in radiology, Divi- 
sion of Radiological Sciences, 
Department of Radiology. 
Francisco Rodriguez, MD, 
instructor in radiology, Divi- 
sion of Diagnostic Radiology, 
Department of Radiology. 
Xiankai Sun, PhD, research 
instructor in radiology, Divi- 
sion of Radiological Sciences, 
Department of Radiology. 
FIRST-YEAR 
FELLOWS  
Scott Andersen, MD, neuro- 
radiology clinical fellow, 
received an undergraduate 
degree and a medical degree 
from Duke University. He 
completed a one-year intern- 
ship at St. Johns Mercy Med- 
ical Center and a diagnostic 
radiology residency (chief 
resident, 2002-2003) at 
Mallinckrodt Institute of 
Radiology. 
Joelle Biernacki, MD, 
magnetic resonance imaging 
clinical fellow, received an 
undergraduate degree and a 
medical degree from the 
University of Missouri, 
Kansas City. She completed 
an internship at the University 
of New Mexico. 
Tedric Boyse, MD, muscu- 
loskeletal radiology clinical 
fellow, received an under- 
graduate degree from Duke 
University and a medical 
degree from Vanderbilt Uni- 
versity. He completed an 
internship at St. Mary's 
Medical Center, San Fran- 
cisco, and a residency at the 
University of Michigan. 
Fadi El-Merhi, MD, 
musculoskeletal radiology 
clinical fellow, received an 
undergraduate degree and a 
medical degree from the 
American University of 
Beirut. He completed an 
internship at The Good 
Samaritan Hospital and a 
residency at Yale-New Haven 
Bridgeport Hospital. 
Aamer Farooki, MD, mag- 
netic resonance imaging clini- 
cal fellow, received an 
undergraduate degree from 
Harvard University and a 
medical degree from Duke 
University. He completed an 
internship at St. Barnabas 
Medical Center and a diagnos- 
tic radiology residency 
at Mallinckrodt Institute of 
Radiology. 
Craig Glaiberman, MD, 
interventional radiology clini- 
cal fellow, received an under- 
graduate degree from the 
University of California and a 
medical degree from the Uni- 
versity of Texas Health Sci- 
ences Center. He completed 
an internship and a residency 
at the Milton S. Hershey 
Medical Center. 
Brett Gratz, MD, abdominal 
radiology clinical fellow, 
received an undergraduate 
degree and a medical degree 
from Duke University. He 
completed an internship at 
Carilion Memorial Hospital 
and a diagnostic radiology 
residency at Mallinckrodt 
Institute of Radiology. 
Peter Hu, MD, interven- 
tional radiology clinical 
fellow, received an under- 
graduate degree from 
Brigham Young University 
and a medical degree from 
the University of Utah. He 
completed an internship at 
MeritCare Hospital and a resi- 
dency at the Medical College 
of Wisconsin. 
Cylen Javidan-Nejad, MD, 
chest radiology clinical fel- 
low, received a medical 
degree from the Iran School 
of Medical Sciences. She 
completed an internship and 
a residency at Henry Ford 
Hospital. 
James Joseph, MD, mag- 
netic resonance imaging 
clinical fellow, received an 
undergraduate degree from 
the University of Richmond 
and a medical degree from 
Ohio State University. He 
completed an internship at 
Riverside Methodist Hospital 
and a residency at the Univer- 
sity of Texas Southwestern. 
Robert Kadner, MD, neuro 
radiology clinical fellow, 
received an undergraduate 
degree from the University of 
Virginia and a medical degree 
from Georgetown University. 
He completed an internship at 
Georgetown University and 
a diagnostic radiology resi- 
dency (chief resident, 2002- 
2003) at Mallinckrodt 
Institute of Radiology. 
Aneel Mandava, MD, inter 
ventional radiology clinical 
fellow, received an under- 
graduate degree from Johns 
Hopkins University and a 
medical degree from the 
University of Maryland. He 
completed an internship at 
the University of Maryland 
Medical System and a resi- 
dency at the Long Island 
Jewish Medical Center. 
Avi Mazumdar, MD, neuro 
radiology clinical fellow, 
received an undergraduate 
degree from Johns Hopkins 
University and a medical 
degree from New York Uni- 
versity. He completed an 
internship at the University 
of California, San Diego, 
and a diagnostic radiology 
residency at Mallinckrodt 
Institute of Radiology. 
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5avid Mueller, MD, muscu- 
loskeletal radiology clinical 
fellow, received an under- 
graduate degree and a Mas- 
ters of Science degree from 
(Washington University in 
ft. Louis, and a medical 
tlegree from the University of 
lissouri, Columbia. He com- 
pleted an internship at 
J3t. Johns Mercy Medical Cen- 
er and a diagnostic radiology 
Residency at Mallinckrodt 
stitute of Radiology. 
idres O'Brien-Solar, MD, 
abdominal radiology clinical 
[fellow, received an under- 
raduate degree and a med- 
ical degree from the Catholic 
Jniversity of Chile. He com- 
Ipleted an internship and a 
residency at the Catholic 
Jniversity of Chile. 
Jason Oliphant, MD, mus- 
culoskeletal radiology clinical 
[fellow, received an under- 
graduate degree and a med- 
Jical degree from Yale 
Jniversity. He completed 
| an internship at Hospital of 
It. Raphael and a diagnostic 
radiology residency at 
Mallinckrodt Institute of 
[Radiology. 
Mmitrios Papadouris, MD, 
interventional radiology clini- 
cal fellow, received an under- 
graduate degree from the 
University of Toronto and a 
[ medical degree from the Uni- 
versity of Western Ontario. 
He completed an internship at 
; Victoria General Hospital and 
a residency at the University 
of British Columbia. 
Naveen Parti, MD, neurora- 
diology clinical fellow, 
received an undergraduate 
degree from Vanderbilt Uni- 
versity and a medical degree 
from Emory University. He 
completed an internship at 
St. Vincent's Hospital and a 
diagnostic radiology resi- 
dency (chief resident, 2002- 
2003) at Mallinckrodt 
Institute of Radiology. 
Srinivasa Prasad, MD, 
abdominal radiology clinical 
fellow, received a medical 
degree from Bangalore Med- 
ical College. He completed 
radiology training at King 
Edward Memorial Hospital 
and a radiology research 
fellowship at Massachusetts 
General Hospital. 
Allan Reier, MD, interven- 
tional radiology clinical 
fellow, received an under- 
graduate degree from the 
University of Miami and a 
medical degree from Jeffer- 
son Medical College. He com- 
pleted an internship at 
Riverside Methodist Hospital 
and a residency at Ohio State 
University. 
Dennis Rivet, MD, neurora- 
diology clinical fellow, 
received an undergraduate 
degree from the U.S. Naval 
Academy and a medical 
degree from Dartmouth Uni- 
versity. He completed an 
internship and a residency at 
Barnes Jewish Hospital. 
Wael Saad, MD, interven- 
tional radiology clinical fel- 
low, received a medical 
degree from Am Shams Uni- 
versity, Faculty of Medicine. 
He completed an internship at 
Union Memorial Hospital and 
a residency at the University 
of Rochester. 
Cary Shlimovitz, MD, neu- 
roradiology clinical fellow, 
received an undergraduate 
degree from the University of 
Texas, Austin, and a medical 
degree from Washington 
University in St. Louis. He 
completed an internship at 
Barnes-Jewish Hospital and 
a diagnostic radiology resi- 
dency at Mallinckrodt 
Institute of Radiology. 
Megan Strother, MD, neu- 
roradiology clinical fellow, 
received an undergraduate 
degree from Princeton 
University and a medical 
degree from the University of 
Arkansas. She completed an 
internship and a residency at 
Wake Forest University. 
Lisa Wang, MD, abdominal 
radiology fellow, received an 
undergraduate degree from 
the Georgia Institute of Tech- 
nology and a medical degree 
from the Medical College of 
Georgia She completed an 
internship at the University 
of Virginia and a residency at 





John Anderson, MD, assis- 
tant in radiology, received an 
undergraduate degree and a 
medical degree from Case 
Western Reserve University. 
He completed an internship at 
Brooke Army Medical Center. 
George Cannon, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
Brigham Young University 
and a medical degree from 
the University of Utah. He 
completed an internship at 
Intermountain Health Care's 
LSD Hospital. 
Jeffrey Carenza, MD, assis- 
tant in radiology, received an 
undergraduate degree and a 
medical degree from Texas 
A&M University. He com- 
pleted an internship at Austin 
Medical Center. 
Kristopher Cummings, MD, 
assistant in radiology, 
received an undergraduate 
degree and a medical degree 
from the University of 
Alabama. He completed an 
internship at Barnes Jewish 
Hospital. 
Gregory dePrisco, MD, 
assistant in radiology, 
received an undergraduate 
degree from Texas A&M Uni- 
versity and a medical degree 
from the University of Texas 
Southwestern. He completed 
an internship at Baylor Uni- 
versity Medical Center. 
Joseph Erinjeri, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
the University of Michigan 
and a medical degree from 
Washington University in 
St. Louis. He completed an 
internship at Virginia Mason 
Hospital. 
Phoebe Freer, MD, assistant 
in radiology, received an 
undergraduate degree from 
Amherst College and a med- 
ical degree from Washington 
University in St. Louis. She 
completed an internship at 
HealthOne Alliance. 
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Heather Garrett, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
the University of Virginia and 
a medical degree from Wash- 
ington University in St. Louis. 
She completed an internship 
at Saint Louis University 
Hospital. 
William Holloway, MD, 
assistant in radiology, 
received an undergraduate 
degree from the University of 
South Carolina and a medical 
degree from the University of 
Chicago Pritzker School of 
Medicine. He completed an 
internship at Louis Weiss/ 
University of Chicago. 
Jack Jennings, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
Wheaton College and a med- 
ical degree from the Univer- 
sity of South Florida. He 
completed an internship 
at the University of South 
Florida Health Sciences 
Center. 
Neil Kennedy, MD, assistant 
in radiology, received an 
undergraduate degree and a 
medical degree from the 
University of Wisconsin. He 
completed an internship at 
St. Luke's Medical Center. 
Michelle Lee, MD, assistant 
in radiology, received under- 
graduate degrees from Saint 
Louis University, Washington 
University in St. Louis, and 
Southern Illinois University 
at Edwardsville, and a med- 
ical degree from Northwest- 
ern University. She completed 
an internship at MetroHealth 
Medical Center. 
Shao Pow Lin, MD, assistant 
in radiology, received an 
undergraduate degree from 
Stanford University and a 
medical degree from Wash- 
ington University in St. Louis. 
He completed an internship 
at St. John's Mercy Medical 
Center. 
John Loh, MD, assistant in 
radiology, received an under- 
graduate degree from the 
University of Michigan and a 
medical degree from Wash- 
ington University in St. Louis. 
He completed three years of 
orthopedic training at the 
University of Pittsburgh. 
Shawyon Shadman, MD, 
assistant in radiology, 
received an undergraduate 
degree from Duke University 
and a medical degree from 
Washington University in 
St. Louis. He completed two 
years of orthopedic training at 
the University of Rochester. 
Michael Smith, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
the University of Utah and a 
medical degree from Wash- 
ington University in St. Louis. 
He completed an internship at 
Carilion Health System of 
Virginia. 
George Wang, MD, assistant 
in radiology, received an 
undergraduate degree from 
Rice University and a medical 
degree from Duke University. 
He completed an internship at 





Randal Anderson, MD, 
assistant in radiology, 
received an undergraduate 
degree from Brigham Young 
University and a medical 
degree from the University of 
Iowa. He completed an intern- 
ship and a residency at the 
University of Iowa Hospitals 
and Clinics. 
Dennis Hsueh, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
the University of California, 
Berkeley, and a medical 
degree from the University of 
Texas, San Antonio. He com- 
pleted an internship at Loma 
Linda University Medical 
Center and a residency at 
the State University of New 
York, Syracuse. 
Akash Sharma, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
the University of Delaware 
and a medical degree from 
Ross University School of 
Medicine. He completed an 
internship at Prince George's 
Hospital Center and a resi- 
dency at Hartford Hospital. 
Feiyu Xue, MD, PhD, assis 
tant in radiology, received an 
undergraduate degree from 
Beying University, a Masters 
of Science degree from 
Tulane University, a medical 
degree from Dartmouth Uni- 
versity, and a doctoral degree 
from Yale University. He com- 
pleted a one-year internship 
at May Imogene Bassett Hos- 
pital and a diagnostic radiol- 
ogy residency at Mallinckrodt 
Institute of Radiology. 
Jane Yang, MD, assistant in 
radiology, received a medical 
degree from Capital Univer- 
sity of Medical Sciences. She 
completed a pediatric radiol- 
ogy fellowship at Long Island 
Jewish Medical Center, a 
diagnostic radiology resi- 
dency at Beying Ji Shui Tan 
Hospital, and a surgical resi- 







Andrew Hope, MD, assistant 
in radiation oncology, 
received a medical degree 
from the University of 
Wisconsin, Madison. He 
completed an internship at 
Aurora Health Care-St. Luke's 
Medical Center. 
MALLINCKRODT INSTITUTE OF RADIOLOC 
.RANTS 
amuel Achilefu, PhD, 
;sociate professor of radiol- 
igy, as principal investiga- 
tor, received a $153,000 
;rant from the National Insti- 
ites of Health to study 
Novel monomolecular multi 
lodality imaging agents." 
loinvestigators for the one- 
ear study are Michael 
relch, PhD, professor of 
iadiology; Barry Siegel, 
MD, professor of radiology; 
MGregory Lanza, MD, and 
jSamuel Wickline, MD, 
■Department of Medicine; and 
Brinton Chance, MD, Univer- 
sity of Pennsylvania. 
] 1 
Mark Conradi, PhD, pro- 
fessor of physics and of 
radiology, as principal inves- 
tigator, received a $150,000 
Irrant from, the Global Envi- 
onmental Management 
initiative (GEMI) Foundation 
or research on "Lung imag- 
ing with C2F6 gas by F-19 
[klR." Coinvestigators for the 
ro-year grant are Jie 
Iheng, PhD, assistant pro- 
fessor of radiology, and 
•mitriy Yablonskiy, PhD, 
»Sc, professor of radiology 
id of physics. 
Jregg Franklin, MD, PhD, 
ssistant in radiation oncol- 
Dgy, received the Siemens 
ledical Solutions/ Radiolog- 
ical Society of North Amer- 
ica (RSNA) Research 
Resident Grant for "A pilot 
study on functional and 
physiologic imaging of the 
salivary glands by magnetic 
resonance imaging on 
patients treated by intensity 
nodulated radiation therapy 
for head and neck cancers." 
Coinvestigators for the 
$30,0000 grant are Joseph 
Deasy, PhD, associate 
professor of radiation 
oncology, and Thomas 
Conturo, MD, PhD, asso- 
ciate professor of radiol- 
ogy. 
Robert Gropler, MD, 
associate professor of 
radiology, of medicine, 
and of biomedical engi- 
neering, as principal inves- 
tigator, received a $3.7 
million grant from the 
National Heart, Lung, and 
Blood Institute of the 
National Institutes of 
Health for "Altered 
myocardial fatty acid 
metabolism in obesity." 
Coinvestigators for the 
five-year grant are Pilar 
Herrero, MS, research sci- 
entist of radiology; and 
Samuel Klein, MD, and Linda 
Peterson, MD, Department 
of Medicine 
Daniel Low, PhD, associate 
professor of radiation oncol- 
ogy, received a three-year 
grant from the National 
Institutes of Health for "Lung 
trajectory mapping." Co- 
investigators for the $1.1 
million grant are Joseph 
Deasy, PhD, associate 
professor of radiation oncol- 
ogy; David Politte, DSc, 
research instructor in radiol- 
ogy; Bruce Whiting, PhD, 
research assistant professor 
of radiology; and Gary Chris- 
tensen, PhD, University of 
Iowa. 
Robert Mach, PhD, profes- 
sor of radiology, received a 
one-year grant of $272,942 
from the National Institute 
on Drug Abuse for research 
on "Development of D3 




(Front row, left to right) Doctors Lilie Lin, Parag 
Parikh, Binh Tran, Gregg Franklin, Fengming Kong, 
Catherine Wu. (Back row) Doctors Angel Blanco, 
Anurag Singh, Wayne Lamoreaux, Andrew Hope, 
Jon Anders, Charles Hechtman. 
Robert McKinstry, MD, 
PhD, assistant professor of 
radiology; Asif Moinuddin, 
MD, research associate; and 
Kathy Grange, PhD, Depart- 
ment of Pediatrics and 
Genetics, are coinvestigators 
for a five-year grant to study 
"Prefrontally-mediated mem- 
ory in phenylketonuria." 
Principal investigator for the 
$1.2 million grant is Desiree 
White, PhD, Department of 
Psychology. The study is 
in collaboration with Ore- 
geon Health and Sciences 
University. 
Tom Miller, MD, PhD, pro- 
fessor of radiology, as princi- 
pal investigator, received a 
$1.7 million grant from the 
National Institutes of Health, 
National Cancer Institute, for 
research on "Positron emis- 
sion tomography in prostate 
cancer." Coinvestigators for 
the five-year grant are Far- 
rokh Dehdashti, MD, asso- 
ciate professor of radiology; 
Barry Siegel, MD, profes- 
sor of radiology; Cary 
Siegel, MD, assistant pro- 
fessor of radiology; Michael 
Welch, PhD, professor of 
radiology; Adam Kibel, MD, 
and Gerald Andriole, MD, 
Department of Urology; Jeff 
Michalski, MD, associate 
professor of radiation oncol- 
ogy; Kathryn Trinkaus, Bio- 
statistics; Peter Humphrey, 
MD, Department of Pathol- 
ogy and Immunology; and 
Nobuyuki Oyama, PhD, 
Fukui Medical University, 
Japan. 
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Steven Peterson, PhD, 
professor of neurology, of 
neurological surgery, of 
anatomy and neurobiology, 
and of radiology, as principal 
investigator, received a $1 
million grant from the 
National Institutes of Health 
for "The study of task-level 
control signals using fMRI." 
Coinvestigators for the grant 
are Randy Buckner, PhD, 
associate professor of psy- 
chology; Larry Jacoby, PhD, 
Department of Psychology; 
and Bradley Schlaggar, 
MD, PhD, assistant profes- 
sor of neurology, of pedi- 
atrics, and of radiology. 
William Powers, MD, pro- 
fessor of neurology, of neu- 
rological surgery, and of 
radiology, as principal inves- 
tigator, received a $5.2 mil- 
lion program project grant 
from the National Institute of 
Neurological Disorders to 
study "Clinical pathophysiol- 
ogy of acute brain injury." 
Coinvestigators are Allyson 
Zazulia, MD; Venkatesh Aiya- 
gari, MD; and Michael 
Diringer, MD, of the Depart- 
ment of Neurology; Tom 
Videen, PhD, research pro- 
fessor of neurology, of neu- 
rological surgery, and of 
radiology; Colin Derdeyn, 
MD, associate professor of 
radiology; and Carmen 
Dence, MS, research scien- 
tist of radiology. 
APPOINTMENTS/ 
ELECTIONS 
Kyongtae Bae, MD, PhD, 
assistant professor of radiol- 
ogy, was elected to an indefi- 
nite term as a member of the 
Radiological Society of 
North America's Education 
Grant Study Section and 
the Research Grant Study 
Section. 
Colin Derdeyn, MD, associ- 
ate professor of radiology, 
was appointed as a consultant 
to the Neurological Devices 
Panel of the Medical Devices 
Advisory Committee for the 
Center for Devices and Radio- 
logical Health of the Food and 
Drug Administration. 
Daniel Low, PhD, associate 
professor of radiation oncol- 
ogy, was appointed to a one- 
year term as vice president, 
facility, for the Hillel Center 
at Washington University in 
St. Louis. 
Elizabeth McFarland, MD, 
associate professor of radiol- 
ogy, was elected to the Asso- 
ciation of University 
Radiologists' 2003-2004 Board 
of Directors as the director of 
the Philips-AUR Faculty 
Development Program. She 
was appointed director for 
Mallinckrodt Institute's Sum- 
mer Research Program. 
Robert McKinstry, MD, 
PhD, assistant professor of 
radiology, was appointed to a 
one-year term on the Neuro- 
radiology/Head & Neck Sub- 
committee of the Scientific 
Program of the Radiological 
Society of North America 
Joel Perlmutter, MD, pro- 
fessor of neurology, of neuro- 
logical surgery, and of 
radiology, was elected to a 
two-year term as a member of 
the Parkinson Study Group 
Executive Committee. He was 
appointed to a three-year 
term on the Standards Com- 
mittee of the Huntington's 
Study Group. 
Steven Peterson, PhD, pro- 
fessor of neurology, of neuro- 
logical surgery, of anatomy 
and neurobiology, and of radi- 
ology, was appointed the 
James S. McDonnell Profes- 
sor of Cognitive Neuroscience 
at Washington University in 
St. Louis. 
Joseph Roti Roti, PhD, pro- 
fessor of radiation oncology, 
was appointed co-chair of the 
Bioelectromagnetic Society 
25th Annual Meeting held in 
Maui, Hawaii, on June 22-27. 
He was appointed as a mem- 
ber of the National Research 
Service Award Study Section 
held in Washington, DC, on 
July 17 and 18. 
Anurag Singh, MD, assistant 
in radiation oncology, was 
elected vice-chairman of the 
Association of Residents in 
Radiation Oncology. He was 
appointed as resident liaison 
to the Education Committee 
and the Refresher Course 
Committee of the American 
Society for Therapeutic Radi- 
ology and Oncology. Singh 
was appointed to the Execu- 
tive Board of the Association 
of Directors of Radiation 
Oncology Programs and as a 
member of the Education of 
Physicians Subcommittee of 
the American Association of 
Physicists in Medicine. 
HONORS/ 
AWARDS 
Kyongtae Bae, MD, PhD, 
assistant professor of radiol- 
ogy, received a Cum Laude 
Award from the Society of 
Computed Body Tomography 
and Magnetic Resonance for 
each of two presentations 
("Principles and practices of 
contrast material delivery for 
MDCT" and "CT coronary 
artery imaging") made at the 
26th Annual Course Meeting in 
April, 2003. 
Christine Menias, MD, 
assistant professor of radiol- 
ogy, received a visiting pro- 
fessorship at the Universidad 
Catolica in Santiago, Chile. 
Bradley Schlaggar, MD, 
PhD, assistant professor of 
neurology, of pediatrics, and 
of radiology, received the 
2003 Young Investigator 
Award, in the amount of 
$20,000, from the Child 
Neurology Society for his 
research on "Development of 
controlled visual lexical pro- 
cessing; fMRI studies." 
24 




\ /ongtae Bae, MD, PhD, 
i sistant professor of radiol- 
bgy, presented "Principle and 
tractice of computer-aided 
liagnosis" to the Department 
k Nuclear Engineering, 
I orean Advanced Institute of 
I echnology and "CT coronary 
tery imaging" to the Depart- 
nent of Radiology, Chung- 
vfam University, DaeJeon, 
■forea, June 4. He spoke on 
"Computer-aided diagnosis in 
liology" at Seoul National 
Jniversity, Department of 
^Computer Science, Seoul, 
Korea, June 5. He presented 
"Computer-aided diagnosis in 
chest radiology" at the Inter- 
national Symposium on 
ssues in Thoracic Radiology: 
Jpdate, Seoul, Korea, June 7 
rid 8. Bae spoke on "Princi- 
ples and applications of 
)CT" at Hyun-Dai Joong- 
Purdy Lecture 
John Wong, PhD, director of 
clinical physics for the Depart- 
ment of Radiation Oncology at 
William Beaumont Hospital in 
Royal Oak, Michigan, presented 
The First James A. Purdy Med- 
ical Physics Lecture on May 16. 
He spoke on "Image guided radi- 
ation therapy: present methods 
and future challenges." Shown 
(left to right) are James Purdy, 
PhD, professor of radiation 
oncology and chief of the Divi- 
sion of Physics; John Wong, 
PhD; and Carlos Perez, MD, pro- 
fessor of radiation oncology and 
chair of the Department of Radi- 
ation Oncology. 
ang Hospital, Asan University, 
Seoul, Korea, on June 10, and 
at Yeong-Dong Severance 
Hospital, Seoul, Korea, June 
13. He presented "MDCT 
made easy" to the Depart- 
ment of Radiology, Sam-Sung 
Hospital, Seonggkyunkwan 
University, Seoul, Korea, June 
10. He spoke on "Radiology 
research in the USA update," 
"Basic body MR physics," and 
"CT coronary artery imaging" 
at the Department of Radiol- 
ogy, Seoul National Univer- 
sity, Seoul, Korea, June 11-13. 
Bae presented "Principles and 
practice of contrast material 
delivery for MDCT" at the 5* 
Annual International Sympo- 
sium on Multidetector-Row 
CT, San Francisco, California, 
June 25-28. He presented 
"MDCT" to the Department of 
Radiology, University of 
Kansas Medical Center, 
Kansas City, Kansas, July 15. 
He spoke on "Technical 
aspects of contrast in CTA 
imaging" at the Applied Radi- 
ology Focus Group for CTA 
Contrast Administration, New 
York City, New York, July 25. 
Jeffrey Bradley, MD, assis- 
tant professor of radiation 
oncology, as invited lecturer, 
presented "PET targeting in 
radiation therapy: applica- 
tions in lung and head and 
neck cancer" at the Case 
Western Reserve University 
PET Symposium, Cleveland, 
Ohio, May 15 and 16. He pre- 
sented "PET/CT for radiation 
therapy planning: the con- 
cepts of biological target vol- 
umes" at the CPS Innovations 
Advisory Board Meeting, New 
Orleans, Louisiana, June 20. 
Colin Derdeyn, MD, associ- 
ate professor of radiology, 
spoke on "Treatment of 
carotid atherosclerotic dis- 
ease: medicine, surgery, or 
stent" at Grand Rounds, 
Salem Public Hospital, Salem, 
Illinois, April 8, and at the 3rd 
Annual Neuroscience Update, 
Carbondale Memorial Hospi- 
tal, Carbondale, Illinois, July 
12. He presented "Cerebral 
hemodynamics in acute and 
chronic ischemia" and 
"Preparing a grant applica- 
tion" at the 41st Annual Meet- 
ing of the American Society of 
Neuroradiology, Washington, 
DC, April 29. 
Louis Gilula, MD, professor 
of radiology and of surgery, 
presented "Lumbar diskogra- 
phy," "Introduction to verte- 
broplasty," and "Lumbar and 
sacral nerve blocks" at Skele- 
tal Radiology 2003, Scotts- 
dale, Arizona, April 6-9. He 
spoke on "Cervical spine 
trauma" and "Plain film 
approach to bone tumors" at 
Oregon Health and Science 
University, Portland, Oregon, 
June 17. 
Perry Grigsby, MD, profes- 
sor of radiation oncology and 
of radiology, presented 
"Positron emission tomogra- 
phy (in gynecologic cancer)" 
at the Annual Gynecologic 
Cancer Conference, St. Louis, 
Missouri, April 25. He spoke 
on "Chemoradiation for cervi- 
cal cancer—who not to treat" 
and "Clinical applications of 
HDR brachytherapy" at the 
9th Annual Conference of the 
Florida Society of Gyneco- 
logic Oncologists, Long Boat 
Key, Florida, June 6. He pre- 
sented "Controversies in cer- 
vical and endometrial cancer" 
at the Semi-Annual Gyneco- 
logic Oncology Group Meet- 
ing & Symposium, Reno 
Nevada, July 24-27. 
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Jay Heiken, MD, professor 
of radiology, spoke on "Pan- 
creatic cancer: evaluation 
with multidetector CT," "CT 
evaluation of small bowel 
obstruction," and "CT 
colonography: What are the 
issues?" at the 33"1 Meeting of 
the Sao Paulo Radiological 
Society, Sao Paulo, Brazil, 
May 14. As a representative 
of the Society of Computed 
Body Tomography and Mag- 
netic Resonance, he pre- 
sented "Ultrasound 
practitioners" at the 
American College of Radiol- 
ogy Intersociety Summer 
Conference, Pasadena, 
California, August 1-3. 
Saulo Klahr, MD, professor 
of medicine and of radiology, 
presented "Obstructive 
nephropathy and renal fibro- 
sis" at the Management of 
Comorbidities in Kidney Dis- 
ease Conference, Long Island 
College Hospital, New 
York City, New York, May 30 
and 31. 
Jason Lewis, PhD, research 
instructor in radiology, pre- 
sented "Cu-ATSM-PET imag- 
ing of hypoxia basic science 
to the clinic" at Memorial 
Sloan-Kettering Cancer Cen- 
ter, New York City, New 
York, June 16. 
Elizabeth McFarland, MD, 
associate professor of radiol- 
ogy, as chair of the Philips- 
AUR Faculty Development 
Program, spoke on "What do 
we value in academics?" at 
the 51s1 Annual Meeting of the 
Association of University 
Radiologists, Miami, Florida, 
April 9-13. She presented "CT 
colonography: Is it ready for 
prime time?" at the Digestive 
Disease Week, Combined 
Clinical Symposium of Virtual 
Imaging of the Colon, spon- 
sored by the American 
Society of Gastroenterology, 
Orlando, Florida, May 19. She 
presented "CT colonography: 
performance to politics" at 
the GI Division Rounds, 
Department of Gastroenterol- 
ogy, Washington University in 
St. Louis, Missouri, June 10. 
Robert McKinstry, MD, 
PhD, assistant professor of 
radiology, spoke on "MRI of 
disorders of brain develop- 
ment" at the 79th Annual 
Meeting of the American 
Association of Neuropatholo- 
gists, Special Course: Mag- 
netic Resonance Imaging of 
Neurological Disease, 
Orlando, Florida, June 19. 
Carlos Perez, MD, professor 
of radiation oncology, pre- 
sented "Brachytherapy in 
carcinoma of the breast," 
"Brachytherapy in carcinoma 
of the uterine cervix," "3D- 
CRT in localized carcinoma of 
the prostate," "Radiation ther- 
apy accidents and quality 
assurance," and "Radiation 
therapy and hormonal ther- 
apy in prostate cancer" at the 
II Jornadas de Radioterapia 
de Alta Complkejidad Braquit- 
erapia y Fiscia Medica, Cor- 
doba, Argentina, July 
31-August2. He spoke on 
"Innovative management of 
bone metastases" at the Cen- 
ter for Cancer Care and 
Research, Lakeland, Florida, 
August 15. 
Joel Perlmutter, MD, pro- 
fessor of neurology, of neuro- 
logical surgery, and of 
radiology, spoke on "10- 
minute neurological exam" 
and "What's shaking in 
Parkinson disease?" at the 
Missouri Academy of Family 
Practice, Osage Beach, Mis- 
souri, June 19. He presented 
"PET imaging of movement 
disorders" at the Society of 
Nuclear Medicine Workshop: 
Modern Imaging Technology, 
New Orleans, Louisiana, June 
20. Perlmutter spoke on 
"PET investigations of ble- 
pharospasm" at the Interna- 
tional Conference of Benign 
Essential Blepharospasm 
Foundation, Philadelphia, 
Pennsylvania, August 23. 
Steven Peterson, PhD, pro- 
fessor of neurology, of neuro- 
logical surgery, of anatomy 
and neurobiology, and of 
radiology, presented "Strate- 
gies for studying cognitive 
development with fMRI" at 
the RIKEN Brain Science 
Institute, Saitama, Japan, 
August 9. 
William Powers, MD, pro- 
fessor of neurology, of neuro- 
logical surgery, and of 
radiology, presented "Cere- 
brovascular disease" at the 
Capri PET Conference, Capri, 
Italy, May 8. He spoke on 
"Logistics and pitfalls of mul- 
ticenter studies with imaging" 
at the National institute of 
Neurological Disorders Sym- 
posium on the Role of Neu- 
roimaging in Parkinson 
Disease, Washington, DC, 
July 10. 
Joseph Roti Roti, PhD, pro- 
fessor of radiation oncology, 
as platform speaker, pre- 
sented "Exposure of C3H 
10T1/2 ceUs to CDMA, FDMA 
or TDMA radiofrequencies 
does not significantly modify 
gene expression" at the Elec- 
tromed 2003 Symposium, San 
Antonio, Texas, June 11-13. 
He presented "Results of 
recent studies to determine if 
RF radiation can induce RNA 
damage" at the 2003 Michael- 
son Conference, West Yellow- 
stone, Montana, August 8-12. 
Stuart Sagel, MD, professor 
of radiology, spoke on "CT 
angiography for pulmonary 
embolism," "Role of CT in 
bronchogenic carcinoma," 
"CT of the thoracic aorta," 
"CT of nonvascular mediasti- 
nal masses," and "Problem- 
atic 'unknown' CT cases" at 
the Rocky Mountain Radio- 
logic Society Meeting, Vail, 
Colorado, July 11-13. He pre 
sented "CT angiography for 
pulmonary embolism: altern 
tive/additional diagnoses," 
"CT of the pericardium," anci 
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T of nonvascular mediasti- 
1 masses" at the Thirteenth 
immer Practicum of the 
.; >ciety of Computed Body 
' omography and Magnetic 
esonance, Asheville, North 
Carolina, July 27-31. 
.radley Schlaggar, MD, 
JhD, assistant professor of 
aeurology, of pediatrics, and 
|f radiology, presented "An 
/IRI strategy for the study of 
cognitive development, 
lessons from a developmental 
udy of controlled lexical 
processing" at the Society for 
Research in Child Develop- 
ment, Tampa, Florida, April 
I 24. He spoke on "Functional 
MRI and cognitive develop- 
ment" at the Department of 
Neurology Grand Rounds, 
Jniversity of Rochester, 
Rochester, New York, May 29. 
Schlaggar presented "A strat- 
egy for the direct comparison 
of children and adults in 
developmental fMRI studies" 
at the Organization for 
luman Brain Mapping Meth- 
ods Workshop Symposium, 
'Jew York City, New York, 
June 19. He presented "Study- 
ng the developmental neuro- 
biology of reading using 
IRI" at the John Merck 
Scholars Fund Summer 
stitute on the Biology of 
developmental Disabilities, 
aceton University, Prince- 
on, New Jersey, July 23. 
lenry Royal, MD, professor 
of radiology, presented "The 
SNM: here today—where is it 
going tomorrow?" and "Radia- 
tion and terrorism: percep- 
tions and realities" at the 481" 
nual Meeting, Southwest- 
ern Chapter of the Society of 
Nuclear Medicine, Oklahoma 
3ity, Oklahoma, April 11-13. 
Barry Siegel, MD, professor 
of radiology and of medicine, 
spoke on "FDG-PET: artifacts, 
variants and benign lesions 
simulating cancer" and "Eval- 
uating tumor response to 
treatment with PET: FDG and 
beyond" at the 48th Annual 
Meeting, Southwestern Chap- 
ter of the Society of Nuclear 
Medicine, Oklahoma City, 
Oklahoma, April 11-13.  He 
presented "PET artifacts/vari- 
ants" and "PET in women's 
imaging" at Clinical Nuclear 
Medicine 2003, sponsored by 
Harvard Medical School, 
Boston, Massachusetts, May 
13-16. As guest speaker, 
Siegel presented "Assessing 
response of cancer therapy 
with PET: FDG and beyond" 
at the Ninth Annual William 
D. Kaplan Lecture, sponsored 
by The Joint Program in 
Nuclear Medicine and Har- 
vard Medical School, Boston, 
Massachusetts, May 13. He 
presented "Interpreting PET 
images" and "PET in oncol- 
ogy: breast and gynecological 
cancers" at PET Imaging for 
the Radiologist, sponsored by 
the American College of Radi- 
ology, Hilton Head, South 
Carolina, June 14 and 15. As 
invited lecturer, Siegel spoke 
on "Current status of PET in 
clinical practice," "PET in 
thoracic oncology," "PET in 
women's cancers," and "PET 
for assessing response to 
therapy: FDG and beyond" 
at the South African Radio- 
logical Congress 2003, 
sponsored by the Radiology 
Society of South Africa, 
Pretoria, South Africa, 
August 15-17. He also spoke 
at Tygerburg Hospital, 
Stellenbosch Medical 
School, Cape Town, South 
Africa, August 26. 
Marilyn Siegel, MD, profes- 
sor of radiology and of pedi- 
atrics, presented "CT of 
pediatric thoracic vascular 
lesions" and "Pediatric CT: 
nonvascular chest applica- 
tions" at the Davos Chest 
Imaging Symposium, Davos, 
Switzerland, April 1-4. She 
spoke on "Ultrasonography of 
the jaundiced child" at the 
American Institute of Ultra- 
sound in Medicine Annual 
Meeting, Montreal, Canada, 
May 3Uune 2. As guest lec- 
turer, Siegel presented "Pedi- 
atric multidetector row CT" at 
the Stanford University 
Annual International Sympo- 
sium on Multidector-Row CT, 
San Francisco, California, 
June 25-28. She presented 
"Multidetector CT in children: 
techniques and applications" 
and "CT/MRI of pediatric 
abdominal masses" at the 
Thirteenth Summer 
Practicum of the Society of 
Computed Body Tomography 
and Magnetic Resonance, 
Asheville, North Carolina, 
July 27-31. 
Anurag Singh, MD, assistant 
in radiation oncology, pre- 
sented "FDG-PET lymph node 
staging: implications for the 
treatment of cervical carci- 
noma" to the Department of 
Radiation Oncology, Univer- 
sity of Maryland, Baltimore, 
Maryland, July 1. 
SYMPOSIA 
In this section of FYI, only 
those faculty and staff who 
have Department of Radiol- 
ogy or Department of Radia- 




103" Annual Meeting 
San Diego, California 
May 4-9, 2003 
SCREENING FOR DISEASE WITH 
CT FORUM 
Elizabeth McFarland, MD, 
"Colon cancer screening: 
interpretation and results." 
CATEGORICAL COURSE 
Barry Siegel, MD, "PET for 
monitoring and predicting 
response to therapy." 
SCIENTIFIC PRESENTATIONS 
Edward Lee, MD, MPH; 
Marilyn Siegel, MD; 
Charles Hildebolt, DDS, 
PhD; Sanjeev Bhalla, MD; 
Fernando Gutierrez, MD, 
"Comparison of multislice 
axial, multiplanar, and 3D 
volume rendering images in 
evaluation of congenital tho- 
racic aortic anomalies." 
Christine Menias, MD, 
"CT of nontraumatic acute 
abdominal pain." 
Srinivasa Prasad, MD, 
"Primary hepatic lymphoma" 
Marilyn Siegel, MD, 
"Neonatal cranial 
sonography." 
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POSTER PRESENTATIONS 
Edward Lee, MD, MPH; 
Christine Menias, MD; 
Amy Hara, MD; Jay 
Heiken, MD; Dennis Balfe, 
MD, "Practical multiplanar 
CT evaluation of small bowel 
obstruction: techniques and 
clinical applications." Certifi- 
cate of Merit Award. 
Edward Lee, MD, MPH; 
Markus Lammle, MD; 
Kianoush Rezaei, MD; 
Vamsidhar Narra, MD; Jef- 
frey Brown, MD, "Practical 
MRI of the liver: principles, 
applications, and protocol— 
a review for the general 
radiologist." 
Srinivasa Prasad, MD; 
Christine Menias, MD; 
Vamsidhar Narra, MD; 
Cary Siegel, MD; William 
Middleton, MD; Sharlene 
Teefey, MD, "Multimodality 
imaging of the female urethra: 
indications, techniques, and 
spectrum" Certificate of 
Merit Award. 
Srinivasa Prasad, MD, "CT 
evaluation of acute gyneco- 
logic conditions." 
Srinivasa Prasad, MD; 
Humberto Rosas, MD; 
Christine Menias, MD; 
Vamsidhar Narra, MD; Jay 
Heiken, MD, "Fat-containing 
liver lesions: radiologic-patho- 
logic correlation." Certificate 
of Merit Award. 
Kianoush Rezaei, MD; 
Markus Lammle, MD; Vam- 
sidhar Narra, MD; Robert 
McKinstry, MD, PhD; Jef- 
frey Brown, MD, "Practical 
MRI of the fetus: principles 
and applications." Certificate 
of Merit Award. 
THE SOCIETY FOR 
PEDIATRIC RADIOLOGY 
46"' Annual Meeting 
San Francisco, California 
May 7-10, 2003 
WORKSHOPS 
Marilyn Siegel, MD, "Multi- 
institutional pediatric cancer 
imaging trials: an update"; 
"Effective screening princi- 
ples: applications in pediatric 
radiology." 
SCIENTIFIC SESSIONS 
Edward Lee, MD, MPH; 
Marilyn Siegel, MD; Fer- 
nando Gutierrez, MD; San- 
jeev Bhalla, MD; Charles 
Hildebolt, DDS, PhD, "Com- 
parison of multislice axial, 
multiplanar and 3D volume 
rendering images in evalua- 
tion of tracheobronchial 
stenosis in children with tho- 
racic vascular anomalies." 
Edward Lee, MD, MPH; 
Marilyn Siegel, MD; 
Charles Hildebolt, DDS, 
PhD, "Abdominal post-trans- 
plant lymphoproliferative 
disorder in pediatric lung 
transplant recipients: an 
unrecognized problem." 
POSTER SESSIONS 
Edward Lee, MD, MPH; 
Marilyn Siegel, MD; Fer- 
nando Gutierrez, MD; San- 
jeev Bhalla, MD; Charles 
Hildebolt, DDS, PhD, "Pedi- 
atric congenital mediastinal 
and pulmonary vascular 
anomalies: a pictorial review 
with emphasis on multidetec- 
tor CT and 3D appearance of 
vascular anomalies." 
MIR in South Africa 
As a Radiological Society of North America (RSNA) 
International Visiting Professor, Marilyn Siegel, MD, 
professor of radiology and of pediatrics, presented "CT 
of common focal hepatic masses," "CT of pediatric 
mediastinal masses," "Pediatric renal masses: multi- 
modality imaging," "Imaging acute abdominal pain in 
children," and "Pediatric pelvic masses: CT and MRI" 
at the South African Radiological Congress 2003, 
sponsored by the Radiology Society of South Africa, 
Pretoria, South Africa, August 15-17. While in South 
Africa, she also presented invited lectures at Pretoria 
Academic Hospital, Johannesburg Hospital, Red Cross 
Hospital, and Ga Rankua Hospital, August 18 and 19. 
The RSNA International Visiting Professor team: (left to right): Doctors Scott 
Pretorius, University of Pennsylvania; Marilyn Siegel; Anina Wilkes, Thomas 
Jefferson Unviersity. 
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fff" Annual Meeting 
New Orleans, Louisiana 
Vune 21-25, 2003 
| Carolyn Anderson, PhD, 
comoderator, Radiopharma- 
ceutical Chemistry Track 
view Chemistry—Oncology II. 
7arrokh Dehdashti, MD, 
noderator, Oncology/Hema- 
alogy Track Oncology— 
Clinical Diagnosis: Melanoma 
ad Thyroid Cancer. 
Jason Lewis, PhD, comod- 
erator, Radiopharmaceutical 
Chemistry Track New Chem- 
y—Other I. 
lobert Mach, PhD, modera- 
3r, Radiopharmaceutical 
Chemistry Track New 
Hhemistry—Oncology I. 
Tom Miller, MD, PhD, chair, 
Scientific Program. 
SCIENTIFIC PAPERS 
Farrokh Dehdashti, MD; 
Jeff Michalski, MD; Car- 
rien Dence, MS; Barry 
Siegel, MD; Michael Welch, 
PhD, "Positron tomographic 
assessment of androgen 
receptors in prostate 
carcinoma" 
Perry Grigsby, MD, "Gyne- 
cologic cancers: clinical and 
PET evaluation." 
Pilar Herrero, MS; Jeffrey 
Baumstark; Deborah 
Delano, RN; Robert Gro- 
pler, MD, "Improved aerobic 
capacity with exercise train- 
ing in the elderly correlates 
with increased myocardial 
fatty acid uptake during 
dobutamine." 
Pilar Herrero, MS; Ziilfia 
Kisrieva-Ware, MD, PhD, 
MD, PhD; Susan Stellhorn, 
RN; Robert Gropler, MD, 
"Impact of dobutamine on 
myocardial substrate metabo- 
lism in type I diabetes." 
Pilar Herrero, MS; Zulfia 
Kisrieva-Ware, MD, PhD; 
Carmen Dence, MS; Paul 
Eisenbeis; Terry Sharp; 
Robert Gropler, MD, 
"Assessment of a mathemati- 
cal model to measure myocar- 
dial glycolysis/oxidation by 
PET with 1-carbon-ll- 
glucose." 
Nobuyuki Oyama, MD, 
PhD; Datta Ponde, PhD; 
Ryuji Higashikubo, PhD; 
Carmen Dence, MS; 
Michael Welch, PhD, "In 
vitro and in vivo assessment 
of 18F-FLT as a proliferation 
marker in prostate cancer 
tumor model." 
Yuan-Chuan Tai, PhD; 
Ananya Ruangma, PhD; 
Richard Laforest, PhD, 
"Performance evaluation of 
the microPET® Focus: a sec- 
ond generation small animal 
PET system." 
Andrei Vlassenko, MD, 
PhD; Melissa Rundle; Mar- 
cus Raichle, MD; Mark 
Mintun, MD, "Lactate injec- 
tion augments increased 
blood flow in physiologically 
activated human brain." 
POSTER SESSIONS 
Jason Lewis, PhD; Robert 
Malyapa, MD, PhD; Ryuji 
Higashikubo, PhD; Michael 
Welch, PhD, "Histological 
comparison of the hypoxia 
selective Cu-ATSM and 
pimonidazole." 
Data Ponde, PhD; 
Nobuyuki Oyama, MD, 
PhD, Carmen Dence, MS; 
Michael Welch, PhD, [I8F]- 
fluoroacetate, an analog of C- 
11 acetate for tumor imaging." 
Ananya Ruangma, PhD; 
Richard I^aforest, PhD; 
Michael Welch, PhD; Mark 
Mintun, MD, "Quantitative 
evaluation of metal artifacts 
on PET data in combined 
PET/CT imaging." 
Zheng Wang, PhD; Michael 
Welch, PhD; Jerrel Rutlin; 
Jason Sohn, PhD, 
"microPET imaging in 
autoimmune uveitis: asym- 
metric lymphadenopathy in 
the secondary lymphoid 
system." 
INTERNATIONAL SOCIETY 
FOR MAGNETIC RESO- 
NANCE IN MEDICINE 
11th Annual Scientific Meet- 
ing & Exhibition 
Toronto, Ontario, Canada 
July 10-16, 2003 
Thomas Conturo, MD, 
PhD, organizer, Diffusion/ 
Perfusion Study Group; 
cochair, Diffusion MRI: To 
Tensor or Not To Tensor; 
cochair, Diffusion Tensor 
Imaging Acquisition 
Methods; cochair, Diffusion 
Tensor Imaging: Clinical 
Applications. 
ORAL PRESENTATIONS 
Thomas Conturo, MD, 
PhD, "Numerical analysis of 
the feasibility of human 
q-space MRI in the case of 
finite-duration diffusion- 
encoding gradients." 
Melanie Kotys; Erbil Akbu- 
dak, PhD; Thomas Con- 
turo, MD, PhD, "Increased 
dose dynamic range and tem- 
poral resolution of AIFs with- 
out additional noise." 
POSTER PRESENTATIONS 
Erbil Akbudak, PhD; 
Joanne Markham, MS; 
Melanie Kotys; Glenn Fos- 
ter, RT; Thomas Conturo, 
MD, PhD, "A high spatial 
temporal resolution AIF 
method for bolus cerebral 
perfusion." 
Melanie Kotys; Erbil 
Akbudak, PhD; Thomas 
Conturo, MD, PhD, 
"Increased dose dynamic 
range and temporal resolution 
of AIFs without additional 
noise." 
AMERICAN ASSOCIATION 
FOR CANCER RESEARCH 
94"' Annual Meeting 
Washington, DC 
July 11-14, 2003 
Douglas Rowland, PhD, 
co-coordinator, 2003-2004 
Associate Member Council 
Program. 
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SCHOLAR-IN-TRAINING AWARD 
Wen Ping Li, PhD, "A radio- 
labeled gelainase inhibitor for 
metalloproteinase 2 and 9 
expression in a murine 
melanoma mouse model." 
POSTER SESSIONS 
Jason Lewis, PhD; Joon- 
young Kim, PhD; Michael 
Welch, PhD, "Tumoricidal 
activity by targeted radiother- 
apy with the hypoxia specific 
agent 64Cu-ATSM is 
enhanced by treatment with 
2-deoxyglucose." 
Weng Ping Li, PhD; Jen- 
nifer Sprague; Carolyn 
Anderson, PhD, "A radio- 
labeled gelatinase inhibitor 
for PET imaging of amatrix 
metalloproteinase 2 and 9 
expression in a murine 
melanoma mouse model." 
Jacob Locke, MD, "Cele- 
coxib enhances cytotoxicity 
of heat shock, reduces ther- 
motolerance and modifies 
HSF and AP-1 activation." 
Girdhar Sharma, PhD; Tej 
Pandita, PhD, "Physical and 
functional interaction of 
HOXB7 with members of 
the NHEJ pathway in breast 
cancer." 
AMERICAN ASSOCIATION 
OF PHYSICISTS IN 
MEDICINE 
45"' Annual Meeting 
San Diego, California 
August 10-14, 2003 
Walter Bosch, DSc, speaker, 
Symposium—RT Extensions 
to DICOM: Do They Really 
Work? 
Joseph Deasy, PhD, chair, 
Scientific Session—Other. 
Eric Klein, MS, cochair, 
Poster Discussion Session— 
Educational. 
Zuofeng Li, DSc, chair, Sci- 
entific Session—IMRT: Plan- 
ning and Optimization. 
Daniel Low, PhD, modera- 
tor, Symposium—IMRT: 
QA—What Is Enough? 
Sasa Mutic, MS, chair, 
Poster Discussion Session— 
Brachytherapy. 
REFRESHER COURSE 
Sasa Mutic, MS, "Use of CT 
and PET in radiotherapy." 
CONTINUING EDUCATION 
COURSE 
Daniel Low, PhD, "IMRT 
system quality assurance." 
SCIENTIFIC SESSIONS 
Joseph Deasy, PhD; Issam 
El Naqa, PhD; Milos Vicic, 
PhD, "Validation maps for 
bias correction in Monte 
Carlo denoising." 
Robert Drzymala, PhD; 
Zuofeng Li, DSc, "A simple 
independent dose calculation 
method for verification of 
treatment time in Gamma 
Knife radio-surgery using inte- 
gral dose." 
Issam El Naqa, PhD; 
Joseph Deasy, PhD; Milos 
Vicic, PhD, "Denoising of 
Monte Carlo dose distribu- 
tions via locally adaptive 
hybrid median filtering." 
Issam El Naqa, PhD; Daniel 
Low, PhD; Joseph Deasy, 
PhD; Michelle Nystrom, 
"Automated breathing motion 
modeling for 4DCT." 
Jian-Yue Jin, PhD; Joseph 
Deasy, PhD; Konstantin 
Zakaryan, PhD, "Open- 
source DICOM and GUI tools 
for treatment planning 
research (WTP)." 
Evgeny Kalinin; Joseph 
Deasy, PhD, "A method for 
fast 3-D IMRT dose calcula- 
tions: the quadrant infinite 
beam (QIB) algorithm." 
Fritz Lerma, PhD; Robert 
Drzymala, PhD, "Practical 
quality assurance of the auto- 
matic positioning system on 
the Leksell Gamma Knife." 
Zuofeng Li, DSc; Sasa 
Mutic, MS; Daniel Low, 
PhD, "Measured 90 degree 
leakage TVLs of photon 
beams from an Elekta linear 
accelerator." 
Daniel Low, PhD, "A novel 
polymerizing radiochrome 
gel." 
Daniel Low, PhD, "Inter- 
comparison of EDR2 and high 
sensitivity radiochromic film 
for measuring small beams." 
Daniel Low, PhD; Milos 
Vicic, PhD; Perry Grigsby, 
MD; Joseph Deasy, PhD; 
Sasa Mutic, MS, "Feasibility 
of a novel small animal con- 
formal teletherapy irradiator 
(microRT)." 
Petr Novak, MSc; Anurag 
Singh, MD; Eduardo 
Moros, PhD; William 
Straube, MS; Andrea Zeug; 
Jacob Locke, MD; Robert 
Myerson, MD, PhD, "Perfor 
mance of a new microPET 
compatible small animal 
hyperthermia system." 
Milos Vicic, PhD; Daniel 
Low, PhD; Perry Grigsby, 
MD; Joseph Deasy, PhD, 
"Monte-Carlo based optimiza- 
tion of a small animal confor- 
mal therapy irradiator 
(microRT)." 
Sasha Wahab, MD; Daniel 
Low, PhD; Issam El Naqa, 
PhD; Parag Parikh, MD; 
Michelle Nystrom; Jeffrey 
Bradley, MD; Sasa Mutic, 
MS, "Use of four-dimenional 
computed tomography in con- 
formal therapy planning for 
lung cancer." 
Bruce Whiting, PhD, 
"Tomographic reconstruc- 
tions from incomplete data 
(WIP)." 
POSTER SESSIONS 
Joseph Deasy, PhD; Kon- 
stantin Zakaryan, PhD, 
"Dose-distance constraints: a 
new method for controlling 
intensity modulated treat- 
ment planning dose 
distributions." 
Joseph Deasy, PhD; Issa 
El Naqa, PhD, "Adaptive 
gridding for IMRT dose 
calculations." 
Jian-Yue Jin, PhD; Sasa 
Mutic, MS; Wade Thorst   I, j 
MD; Daniel Low, PhD; 
Fengming Kong, MD; Perry I 
Grigsby, MD; James Pur      | 
PhD, "Study of field match in 
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ivgeny Kalinin; Issam El 
>? ;qa, PhD; Parag Parikh, 
I   ), "Quantitative spirometiy 
f,   4D computed tomography." 
|f<Yitz Lerma, PhD; Sasa 
lutic, MS; Daniel Low, 
PhD, "Peripheral doses 
resulting from SMLC MET 
delivery." 
■aniel Low, PhD; Sasha 
ahab, MD; Issam El 
"•aqa, PhD; Parag Parikh, 
; Michelle Nystrom; 
Svgeny Kalinin; Jeffrey 
Sradley, MD; Anurag 
Singh, MD; Sasa Mutic, MS, 
[ "Four-dimensional computed 
tomography using a 16-slice 
Muardo Moros, PhD; Petr 
iMovak, MSc; Prashant Kol- 
luri; William Straube, MS, 
"Ultrasound phantoms with 
bone inclusions to study the 
thermal effect of underlying 
i bone on SAR and tempera- 
ture distributions in superfi- 
cial hyperthermia." 
Petr Novak, MSc; Eduardo 
Moros, PhD; William 
Straube, MS; Robert Myer- 
son, MD, PhD, "Preclinical 
testing of a system for simul- 
taneous ultrasound hyper- 
thermia and radiation beam 
therapy." 
Konstantin Zakaryan, PhD; 
Joseph Deasy, PhD, "Adap- 
tive colormaps for reviewing 






15°' Annual Meeting 
Sydney, Australia 
August 10-14, 2003 
SCIENTIFIC SESSIONS 
Carolyn Anderson, PhD; 
Wen Ping Li, PhD; James 
Kozlowski; Zhaohui Zhou, 
PhD; Daniel Schuster, MD, 
"Evaluation of Cu-64-DOTA- 
CTT, a MMP-9 inhibitor, as a 
potential PET lung inflamma- 
tion imaging agent." 
Heather Bigott, Michael 
Welch, PhD, "Synthesis of 
rhenium/technetium labeled 
estrogen receptor imaging 
agents: evaluation using 
microPET with technetium- 
94m." 
Charles Boswell; Xiankai 
Sun, PhD; Carolyn Ander- 
son, PhD, "In vivo stability of 
Cu-64-azamacrocyclic com- 
plexes: comparison of Teta 
and Dota with cross-bridged 
chelators." 
Carmen Dence, MS; Joon- 
young Kim, PhD; Xiankai 
Sun, PhD; Richard Lafor- 
est, PhD; Michael Welch, 
PhD, "Synthesis, microPET 
imaging, biodistributiuon and 
dosimetry data of D- and L- 
3[uC]lactic acid." 
Jason Lewis, PhD; Jerrel 
Rutlin; Lynne Jones; 
Michael Welch, PhD, "Cu 
64-complexes targeted at 
topoisomerase-II, a regulatory 
enzyme for DNA topology." 
MIR Reunion 
While in Sydney, Australia, far the International Symposium for Radiophar- 
maceutical Chemistry, Michael Welch, PhD, cochief of the Division of Radio- 
logical Sciences, hosted a reunion for 52 past and present members of the 
Radiological Chemistry Laboratory. Left to right: Xiankai Sun, PhD; Jeongsoo 
Yoo, PhD; Welch; Yashuisa Fujibayashi, PhD, DMedSci, from Japan's Fukui 
Medical University; and Jim Wang, PhD. In 1999, Fujibayashi and Welch 
coordinated an academic and cooperative research agreement between MIR 
and Fukui University. 
With Welch are (left to right) Jennifer Sprague, Amy Vavere, Andrew 
Boswell, and Heather Bigott—Radiological Chemistry Laboratory graduate 
students who presented scientific papers at the meeting in Australia. 
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Richard Laforest, PhD; 
Ananya Ruangma, PhD; 
Jason Lewis, PhD; Xiankai 
Sun, PhD; Michael Welch, 
PhD, "microPET imaging of 
radiopharmaceuticals labeled 
with three copper radionu- 
clides." 
Jason Lewis, PhD; Jin- 
Hwan Kim, PhD; Michael 
Welch, PhD, "microPET 
imaging of the effects of 
tumorcidal 2-deoxy glucose." 
Robert Mach, PhD; Wenhua 
Chu; Zhude Tu, PhD; Car- 
men Dence, MS; Michael 
Welch, PhD, "["C]PJ34: a 
PET radiotracer for imaging 
theroleofPARP-lin 
necrosis." 
Paul McQuade, PhD; Jason 
Lewis, PhD; Michael Welch, 
PhD, "wCu labeling and evalu- 
ation of the metallopeptide, 
DOTA-reCCMSH(Argl 1), 
a cyclized alpha-MSH 
analogue." 
Douglas Rowland, PhD; 
Zhude Tu, PhD; Robert 
Mach, PhD; Michael Welch, 
PhD, "Investigation of a new 
sigma 2 receptor ligand for 
detection of breast cancer." 
Jennifer Sprague; Xiankai 
Sun, PhD; Laura Meyer; 
Samuel Achilefu, PhD; Car- 
olyn Anderson, PhD, "In 
vivo behavior of copper-64 
labeled Y3-octreotate using a 
cross-beidged cyclam ligand." 
Xiankai Sun, PhD; Joel 
Garbow, PhD; Jason Lewis, 
PhD; Jerrel Rutlin; Carolyn 
Anderson, PhD; Michael 
Welch, PhD, "Multi-modality 
imaging studies on osteolytic 
bone metastasis." 
Lucie Tang, BscA; Douglas 
Rowland, PhD; Debbie Sul- 
tan, PhD; Michael Welch, 
PhD, "Remote separation 
procedure for halogen 
production." 
Amy Vavere; Michael 
Welch, PhD, "microPET 
imaging of a titanium-45 
labeled titanocene complex to 
delineate biodistribution of 
titanium anti-cancer drugs." 
Zhing Wang, PhD; David 
Reichert, PhD; Wouter 
Nagengast, "microPET imag- 
ing studies of the initiation and 
progression of a murine model 
of rheumatoid arthritis." 
Special Award 
At the April meeting of the 
American Radium Society 
(ARS), Robert Malyapa, 
MD, PhD, assistant profes- 
sor of radiation oncology, 
received the ARS Young 
Oncologist Essay Award 
for his talk on "ERK lh 
activation is associated 
with poor prognosis in 
hypoxic cancers of the 
uterine cervix." At left is 
Frank Wilson, MD, ARS 
president. 
Jeongsoo Yoo, PhD; David 
Reichert, PhD; Peter Wolo- 
han, PhD; Michael Welch, 
PhD, "Regioselectively N- 
substituted cyclens: synthesis, 




PhD; Michael Welch, PhD, 
"A new synthesis procedure 
of [18F]FFNP for in vivo imag- 
ing of progestin receptors." 
Pilar Herrero, MS; Zulfia 
Kisrieva-Ware, MD, PhD; 
Carmen Dence, MS; Paul 
Eisenbeis; Terry Sharp; 
Robert Gropler, MD, 
"Assessment of a mathemati- 
cal model to measure myocar- 
dial glycolysis/oxidation by 
PET and I-carbon-11-glucose." 
Paul McQuade, PhD; Lynne 
Jones; Michael Welch, 
PhD, ""mTC and MCu labeled 
annexin-V, positron emitting 
radiopharmaceuticals to 
study apoptosis." 
Paul McQuade, PhD; Jason 
Lewis, PhD, Investigation 
into improved imaging agents 
for cardiovascular and neuro- 
logic hypoxia." 
David Reichert, PhD; Zhi» 
Wang, PhD, "Approaches 
to the in vivo PET imaging 
of T cells in adoptive 
immunotherapy." 
Xiankai Sun, PhD; Carolyn 
Anderson, PhD, "In vivo 
evaluation of indium- 
111-labeled cross-bridged 
tetraazamacrocyclic ligands." 
Lucie Tang, BScA; Gregory 
Gaehle; Jason Lewis, PhD; 
Michael Welch, PhD, "Auto 
mated separation, purification j 
and labeling systems for cop- 
per isotopes (^Cu, 61Cu, MCu)." 
Zhude Tu, PhD; Suwanna 
Vangveravong; Carmen 
Dence, MS; Robert Mach, 
PhD, "Conformationally- 
flexible benzamide analogues 
as dopamine D3 receptor 
imaging agents for PET and 
SPECT." 
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(Seated, left to right) Doctors Andrew Bierhals; Cynthia Santillan; Heather Byer; Wincha Chong; Scott 
Andersen, diagnostic radiology chief resident; Naveen Parti, diagnostic radiology chief resident; Gilbert 
Jost, director of the Institute; Christine Menias, assistant director, Diagnostic Radiology Residency 
Program; Robert Kadner, diagnostic radiology chief resident; Jason Bronfman; Ronald Gerstle; 
Kianoush Rezaei; Christian Schmitt. (Second row) Doctors Vladislav Gorengaut, Nelson Elkins, Yuliya 
Lakhman, Markus Lammle, David Mueller, Creed Rucker, Karun Sharma, Aamer Farooki, Anand Singh, 
Gregory Sanders, Ryan Murtagh, Kevin Lee, David Johnston, Daniel Wessell, Franklin Marden, Cary 
Shlimovitz, Jason Wagner, Jayson St. Jacques, Brett Gratz, Howard Harvin, Ningmei Hu, Michelle 
Dorsey, Bonnie Joe, Jennifer Lee, Tammie Benzinger. (Third row) Doctors Ashesh Parikh, Scott Bolton, 
Krishna Thirumala, Ryan Cook, Jason Kerr, Archie McGowan, Merhdad Sehizadeh, Srinivasa Prasad, 
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